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Abstract 
Streptomyces venezuelae ATCC10712 which is an object of research investigation during this 
master thesis belongs to Actinomycetales which are widely recognized as a producer of 
antibiotics. Secondary metabolites synthesis in S. venezuelae varies depending from the 
conditions of incubation. If stress factors like ethanol are present in the medium, 
microorganism switches to production of jadomycin. In normal conditions however, nutrient 
depletion leads to subsequent synthesis of chloramphenicol. Regulation of aforementioned 
compounds is precisely, internally regulated by the set of adjacent genes. jadR1 and jadR2 
were identified as genes having major influence in these pathways. 
The idea of this project was to re-engineer the antibiotic biosynthesis regulatory circuit of 
chloramphenicol and jadomycin in S. venezuelae, in order to make recombinant strain’s 
chloramphenicol production dependent on ethanol stress. Following steps took place to 
achieve this goal.  
Firstly, construction of recombinant strain with deletion of jadJ-E structural genes from  
S. venezuelae chromosome and their replacement with a reporter gene gusA. Another 
assembly was constructed with the aim of replacing cmlI-X promoter in deletion mutant with 
jadR1-jadJ promoter region in the chloramphenicol biosynthetic gene cluster. Planning was 
based on the fact that since those genes are under negative regulation of JadR1 regulator, 
exchange of the promoter will lead to its activation and subsequent chloramphenicol 
biosynthesis. Due to the difficulties which arose from the mutations in gusA gene, additional 
assembly with the deletion of of jadJ-E genes in S. venezuelae with another version of gusA 
region had to be constructed.   
Chloramphenicol production was assessed in S. venezuelae mutant carrying substituted 
promoter by UPLC analysis. Results revealed 5 fold increase of chloramphenicol expression 
under ethanol shock in recombinant strain, in comparison with wild-type S. venezuelae in the 
same conditions. When uninduced, mutant produced no chloramphenicol. This experiment 
was the main objective of this master thesis. 
In addition, construct for heterologous expression of chloramphenicol antibiotic gene cluster 
in Streptomyces albus was assembled. Strain was assessed for the production of this antibiotic 
by UPLC analysis.  
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Introduction 
I. The discovery, biology and classification of Actinomycetes 
Actinomycetes were firstly described in 1877 as a causative agent of “lumpy jaw” disease 
which was found in cattle. Symptoms were manifesting in the form of severe swellings on the 
side of the face caused by proliferation and unnatural deviation of the bone. After certain 
period of time this resulted in an animal’s difficulty to eat. Carl Otto Harz (1842-1906) was 
the first one to elucidate the morphological structure of the causative organism. Mistakenly, 
due to similar appearance, he thought it was a fungus. For this reason he called it Actinomyces 
which means “ray fungus”. In 1875 Ferdinand Cohn (1828-1898) published his observations 
of a range of microbes. He included one called Streptothrix foesteri where streptothrix means 
“twisted hair”. Second part of the name originates from his friend, R. Foerster who provided 
material for his research. In 1916, R.E. Buchanan recognized officially group 
Actinomycetales. Due to multiplicity of the names, classification of this group was very 
problematic at the beginning. In 1943 another attempt to classify Actinomycetes has been 
done by S. Waksman and Henrici. The degree of branching was used as a main criterion to 
divide organisms into three groups. Two of them were subdivided afterwards, what resulted in 
five genera altogether. Moreover, Streptomyces (“twisted fungus”) name emerged and 
replaced previous one – Streptothrix. Results of their work are presented in Figure 1.  
Established classification was based on morphology of the microorganism. Relationships 
between species however still remained unresolved. Until later, when Waksman decided to 
research soil microorganism, Actinomycetes seemed not to be considered a group of interest. 
The key observation which led to further findings was that disease-causing bacteria survive in 
a soil only for a short period of time. Further on, he assumes that this has to happen due to soil 
microbes which are actively destroying them.  
Term antibiotic was invented by P. Vuillemin in 1889. At this time, it was described as a 
destruction of one organism by the other. Waksman proposed to modify it with the respect to 
the origin of the compound – synthetic or natural. In this way, following description emerged: 
“chemical substances that are produced by microorganism and that have the capacity, in dilute 
solution, to selectively inhibit the growth or even to destroy other microorganism”.  
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Sometime after the discovery of Penicillin it became known that it is influencing only gram-
positive bacteria. For this reason, Waksman decided to focus on the other group of 
microorganisms – gram-negative ones. As he committed his life to finding new antibiotics, he 
started screening different soil microorganisms. First test group consisted of three of them: 
bacteria, fungus and actinomycetes. Last one turned out to be amazingly productive, with 106 
strains out of 244 which exhibited antibiotic properties. Year 1943 happened to be a 
breakthrough in Waksman’s research. One of his graduate students, Albert Schatz discovered 
an antibiotic produced by a strain of Streptomyces griseus which was effective both against 
gram-negative pathogens and also tubercule bacillus. This led Waksman to be awarded with 
Nobel Prize for Physiology or Medicine in 1952 (Hopwood, 2007). 
  
 
Figure 1. Classification of the actinomycetes by Waksman and Henrici. Scanning 
electron micrographs (Hopwood, 2007). 
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1. Actinomycetes 
As it was mentioned before, actinomycetes belong to prokaryotes. Their genomes are 
approximately 8-10 Mb in size, and they contain 20-30 gene clusters encoding secondary 
metabolites (Siegl and Luzhetskyy, 2012). Actinomycetes were isolated from many natural 
habitats such as soil, marine and lake water, insects, sand, pollen grain (Mahajan and 
Balachandran, 2012). 
Gram-positive bacteria can be subdivided into following groups: low G+C organisms – which 
include for instance: Bacillus, Clostridium, Staphylococcus and Streptococcus and high G+C 
organisms – actinomycetes. Latter ones tend to develop mycelia which is considered to be a 
hallmark of actinomycetes. Formation of branched threads and rods comprise characteristics 
of their growth. They frequently give a rise to unicellular mycelium. Mycelium may be of two 
types: vegetative – growing in the substrate or aerial – which means, that it is produced above 
the vegetative growth. Hyphae, which are generally not-separate may dissociate under special 
conditions. Strains of Streptomyces are characterized by the presence of aerial mycelium. 
Reproduction of actinomycetes involves either special sporulating bodies or parts of 
vegetative mycelium (Mahajan and Balachandran, 2012). It is important to note however, that 
some actinomycetes do not form aerial mycelium, and do not sporulate. Thus, the most 
important taxonomic tool in classification of actinomycetes is a partial sequence analysis of 
16S ribosomal RNA (Kieser et al., 2000). 
2. Streptomyces 
Microorganism which was an object of this master thesis is Streptomyces venezuelae 
ATCC10712. 
Streptomyces contain large linear chromosome and were identified by presence of LL isomer 
of diaminopimelic acid (LL-DAP) as the diamino acid in the peptidoglycan. This feature 
combined with characteristic substrate and aerial mycelium was a diagnostic feature of 
Streptomyces (Dyson, 2009; Kieser et al., 2000). 
Morphological development of Streptomyces is a quite complex process which includes four 
phases: mycelial growth, multicellular behaviour, intercellular communication and 
morphological differentiation. Life cycle ends with production of spores, as presented in 
Figure 2. 
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When the spore is placed in an optimal environment, it starts to germinate. This includes 
swelling of the spore, establishment of the call polarity and apical growth. In addition, it leads 
to the outgrowth of one or more hyphae. The hyphae grow into mycelia networks by tip 
extension and branching. Due to this networks Streptomyces reminiscence more filamentous 
fungi than other bacteria (McCormick and Flärdh, 2012).  
 
  
Figure 2. Development of Streptomyces (Brooks et al., 2012). 
 
Streptomyces produce antibiotics in the soil which makes them potential antagonists for soil-
borne pathogens. Production of antibiotics appears to be growth phase-dependent. In liquid 
culture, biosynthesis starts as culture enters stationary phase. In solid agar plates, it starts with 
the stage of morphological differentiation. Antibiotics are produced as a result of expression 
of specific gene clusters (Kieser et al., 2000). 
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II. Antibiotics 
Up to date definition of antibiotics runs as follows: substances produced as a secondary 
metabolites by many bacterial, fungal and some animal species. They are not required for a 
normal growth of the organism. They possess antibiotic activity that is one which inhibits the 
growth or kill other living organism (Behal, 2000).  
The function of these compounds is undergoing an extensive debate. Some say, they inhibit 
the growth of competing organisms in order to allow others take an advantage from 
surrounding environment (Zotchev, 2012). On the other hand, many researchers think that this 
is rather form of a defence of a colony biomass against overgrowth by other organism during 
the autolysis at the certain stage of development (Chater et al., 2010). Concentration of 
antibiotics is however very low in natural conditions, which may imply the other alternatives. 
Antibiotics are known to modulate gene expression in bacteria in subinhibitory concentrations 
(Zotchev, 2012). This may imply role as a signalling molecules which provide ways of 
communication between different species. In addition, microorganisms might control the 
development of themselves by producing signals promoting aerial growth and sporulation or 
inhibitors of spore germination. In symbiotic interactions, antibiotics protect a symbiotic 
partner against infection by other microorganism (Chater et al., 2010).  
Production of antibiotics is species specific. Actinomycetales produce over 60% of all 
compounds with antibiotic activity (Zotchev, 2012). 
1. Discovery of Penicillin 
Development of antibiotics started with discovery of penicillin. In summer 1928 Alexander 
Fleming who was a physician and bacteriologist at Inoculation Department at St. Mary’s 
Hospital in London came back from long holidays and to his surprise noticed large splotch of 
mould on the plate which he previously inoculated with staphylococcus bacteria. The fact 
wouldn’t be anything weird except that there was significant growth inhibition zone of 
growing staphylococci around the mould. Due to his previous work on disintegration effect of 
lysosyme on bacteria, Fleming recognized growth inhibition phenomenon. After closer 
investigation he discovered that the mould belongs to the type of Penicillium and besides 
staphylococci, affects whole range of other bacteria. This research led to publication about 
substance called “penicillin” in 1929. Discovery of penicillin was connected with whole series 
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of lucky coincidents. Firstly, it turned out that the spore of mould didn’t come from the 
random spore happened to drift around in the air. It appears it came from the laboratory of 
mycologist – C. J. La Touche which was located just on the floor below. Also, since penicillin 
exerts the effect only on growing bacteria, arrival of the spore, timing of Fleming’s vacation 
and local weather at this time put a mark on this remarkable discovery. Due to the difficulties 
on the way connected with lack of knowledge and problems with repetition of the experiment, 
penicillin research was dropped until the decade after. In late 1930s Ernst Chain and Howard 
Florey stumbled upon penicillin while researching the effects of lysozyme on disintegration of 
cell wall in bacteria. Due to his biochemistry background Chain managed to produce a small 
amount of concentrated penicillin which started miraculously curing people without evoking 
any toxic effect. With the time and other fortunate incidents production was upscaled and in 
1944 there was enough penicillin to treat masses of people (Queijo J., 2010).     
2. Classification of antibiotics 
Since Fleming times, several classes of antibiotics have been developed. Representatives of 
each along with their bioactivity and mechanism of action are summarized in the table below. 
Table 1. Classification of antibiotics (Coates et al., 2011; Moore, 2013). 
Class Representatives Biological activity 
Mechanism of 
action 
β-lactamase 
inhibitors 
clavulanate Staphylococcus aureus; 
Staphylococcus 
epidermis; 
Escherichia coli; 
Klebsiella; 
 
Cell wall 
synthesis 
inhibition 
β-lactams 
(Penicillins) 
penicillin G Gram-positive bacteria 
 
 
Cell wall 
synthesis 
inhibition 
Aminoglycosides gentamycin Aerobic Gram-negatives; 
Enterobacteriaceae;  
Pseudomonas; 
 
Protein synthesis 
inhibitors (inhibit 
30S subunit) 
Angucyclines jadomycin Gram-positive;  
Gram-negative bacteria; 
Yeast; 
Antifungal; 
Antitumor;  
 
Exact mechanism 
not elucidated yet 
Bacitracin bacitracin Topical Gram-positive Cell wall 
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infections 
 
synthesis 
inhibition 
Carbapenems imipenem Very broad activity 
(except MRSA, 
Mycoplasma) 
 
Cell wall 
synthesis 
inhibition 
Cephalosporins First generation: 
cephalothin  
 
 
 
 
Second generation: 
cefprozil 
 
Third generation: 
cefotaxime  
 
 
Fourth generation: 
cefpirome  
 
 
 
 
 
 
 
 
 
Fifth generation: 
ceftaroline 
S. aureus; 
S. epidermidis; 
Some Gram-negatives: 
E. coli; 
Klebsiella; 
 
Above + 
↑ Gram-negative 
 
Above + 
↑ Gram-negative 
Pseudomonas 
 
Above + 
↑ Gram-negative 
Bacteroides spp.;  
Haemophilus influenzae  
Moraxella catarrhalis;  
Morganella morganii; 
Providencia rettgeri; 
Serratia spp.;  
Streptococcus pneumonia;  
Streptococcus pyogenes;  
 
Above + 
↑ Gram-negative + 
resistant phenotypes 
 
Cell wall 
synthesis 
inhibition 
Chloramphenicol chloramphenicol H.  influenza; 
Bacterial meningitis; 
Brain abscess; 
  
Protein synthesis 
inhibitors (inhibit 
50S subunit) 
Glycopeptides vancomycin MRSA; 
Penicillin/Cephalosporin 
allergies 
S. aureus; 
S. epidermidis; 
 
Cell wall 
synthesis 
inhibition 
Ketolides telithromycin Gram-positive bacteria; 
some intercellular 
pathogens; 
 
Protein synthesis 
inhibitors (inhibit 
50S subunit) 
Lincosamides clindamycin Bacteroides fragilis; Protein synthesis 
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S.  aureus; 
Coagulase-negative 
Staphylococcus & 
Streptococcus; 
Protozoa; 
 
inhibitors (inhibit 
50S subunit) 
Lipopeptides daptomycin Gram-positives Disruption of the 
cell membrane 
Macrolides erythromycin Streptococcus; 
H. influenza; 
Mycoplasma pneumoniae; 
 
Protein synthesis 
inhibitors (inhibit 
50S subunit) 
Monobactams aztreonam Aerobic Gram-negatives 
 
Cell wall 
synthesis 
inhibition 
Oxazolidinones linezolid Resistant Gram-positives Protein synthesis 
inhibitors (inhibit 
50S subunit) 
Polimyxins polimyxin B Topical Gram-negative 
infections 
 
Disruption of the 
outer membrane 
Quinolones nalidixic acid Steptococcus; 
Mycoplasma; 
Aerobic Gram-positive; 
 
DNA Synthesis 
Inhibitors 
Rifamycins rifampicin (also called 
rifampin) 
Staphylococcus; 
Mycobacterium 
tuberculosis; 
 
RNA synthesis 
Inhibitors 
Streptogramins quinupristin VRE; 
GAS; 
 S. aureus skin infections; 
 
Protein synthesis 
inhibitors (inhibit 
50S subunit) 
Sulphonamides sulfamethoxazole UTI organisms; 
Proteus; 
Enterobacter; 
 
Folic Acid 
synthesis 
inhibitors 
Tetracyclines tetracycline Rickettsia; 
Mycoplasma; 
Spirochetes;  
Protein synthesis 
inhibitors (inhibit 
30S subunit) 
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3. Chloramphenicol 
Chloramphenicol is a compound which was isolated from Streptomyces species from a soil 
sample obtained from a field near to Caracas. Due to the place where it has been found, 
bacterium got the name Streptomyces venezuelae.  
Chloramphenicol is a small molecule, poorly soluble in water. It exists in four possible 
stereoisomers but only one of them possesses antibacterial activity.  
 
Figure 3. Chloramphenicol structure (Anderson et al., 2012). 
Experiments have shown that chloramphenicol has very broad spectrum of action. It exhibits 
both bacteriostatic and bactericidal activity against various strains of gram-positive and gram-
negative bacteria, spirochetes and obligatory intracellular pathogens like mycoplasma or 
chlamydiae. In the treatment of typhoid it is considered as a drug of a choice (Mahajan and 
Balachandran, 2012).  
Mechanism of action involves binding to the large ribosomal subunit – 50S at the peptidyl 
transferase centre A site. In this way it prevents binding next charged tRNA and overall 
inhibits protein synthesis. It appears that chloramphenicol binds very selectively. The reason 
for that may be difference in conformation between bacterial and eukaryotic peptidyl 
transferase. Experiments have shown that it binds only to bacterial ribosome (Anderson et al., 
2012). 
It was firstly released on the market as Chloromycetin. Nowadays it is manufactured 
completely synthetically. It is sold as a chloramphenicol palmitate ester which is its inactive 
form. Hydrolysis in the gastrointestinal tract allows it to be absorbed as a free molecule 
(Mahajan and Balachandran, 2012). 
Due to the risk of developing serious haematological effects, systemic use of chloramphenicol 
is highly restricted. It is used only in life-threatening infections caused particularly by 
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Haemophilus influenza. Topical use of chloramphenicol is quite common, especially in the 
superficial eye infections (Anderson et al., 2012). 
4. Jadomycin 
Jadomycins are a class of angular tetracyclines which is called angucyclines. They are also 
considered as members of type II polyketides (PKSII) produced by S. venezuelae (Cossy and 
Arseniyadis, 2012). On the contrary to chloramphenicol, jadomycin is produced only under 
specific conditions i.e. induction by heat shock, ethanol stress or phage infection.  
 
Figure 4. Jadomycin B structure (Sharif and O’Doherty, 2012). 
They consist of 8H-benzo-[b]-phenanthridine backbone with fused nitrogen and oxygen in 
various combinations (Sharif and O’Doherty, 2012). PKSII-derived natural product contains 
five-membered oxazolone ring. Formation of oxazolone ring happens via reaction of amino 
acid from the culture medium with biosynthetic aldehyde precursor. This results in reactive 
aldimine which undergoes several latter reactions (Jakeman et al., 2009). Jadomycin B which 
is a focus in this thesis is glycosylated with a L-digitoxose sugar unit. Glycosylation exerts its 
role in the bioactivity of the compound formed (Sharif and O’Doherty, 2012). 
Jadomycin biosynthesis happens in nutrient-deprived amino acid rich medium. The way to 
achieve this condition is exhaustion of carbon, nitrogen or phosphate from the medium 
together with supplying it with amino acids. Production is induced by the factors mentioned 
before like ethanol and heat shock (Brooks et al., 2012). 
Depending on the amino acid provided in the medium, jadomycin has several analogues B, L, 
F, G, Y, N. Different types arise from aromatic, polar, aliphatic α-L-amino acids and α-D- 
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amino acids. Incorporation of such a novel non-natural amino acids broadens the potential of 
the secondary metabolites (Jakeman et al., 2005). 
Jadomycins are broad spectrum antimicrobials, and were found to be active against gram-
positive, gram-negative bacteria and yeast. However, they tend to give better effect against 
gram-negative microbes. Additionally, it was proven that they demonstrate antitumor, 
antifungal, enzyme inhibitory and cytotoxic activity to cancer cells (Brooks et al., 2012; Rix 
et al., 2004). 
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III. Regulation of antibiotic gene clusters 
1. Antibiotic biosynthesis gene clusters and its regulation 
Microorganisms are very rich reservoir of antibiotics and other biologically active secondary 
metabolites. Function of many of them is still unknown. Before sequencing and analysis of 
Streptomyces coelicolor genome in 2002, many thought natural sources for discovery of new 
compounds might become depleted and finding new ones may be excessively difficult. . This 
was mainly induced by the high rediscovery rate of compounds which were already known. 
With the development of sequencing technology i.e. in 2002, researchers came across 
amazingly high numbers of chemical diversity encoded in antibiotic clusters which were not 
detected before. It turned out that each strain has a potential to produce 20-40 distinct 
secondary metabolites. Reason for not noticing them before could be unstable, no or very low 
expression level, undetectable with up-to-date methods. Need for understanding rich 
actinomycetes genomes promoted development of new approaches and tools. This was a 
beginning of a new era for bioprospecting. Efforts of the researchers started to be redirected 
from environmental screening and rather focused on studies on regulation mechanisms. It was 
discovered that stress responses like heat or ethanol shock may induce expression of silent 
gene clusters. An example of this type of regulation is production of jadomycin B from S. 
venezuelae (Zotchev et al., 2012; Rebets et al., 2014; Yoon and Nodwell, 2014). In addition, 
Brian Bachmann and John McLean, biochemists at Vanderbilt University discovered while 
investigating development of bacterial drug resistance that many bacteria in response to 
antibiotic assault express hundreds of compounds which are not produced by their wild types. 
Some of them have a potential to be a novel secondary metabolites (Derewacz et al., 2013). 
Cryptic antibiotic clusters are detected with the help of several technologically-advanced 
bioinformatic tools like antiSMASH or SBSPKS software which allows localizing them in the 
organisms like bacteria and fungi. In addition, it provides information about cluster 
abundance and potential produced substance, which may facilitate estimation of probability of 
discovery a novel compound. Finding a cluster of interest is followed by wet-lab approaches 
aiming its activation by inactivation of a repressor, overexpression of positive regulator or 
heterologous expression. Modern synthetic biology approaches helping in achieving this goal 
will be described in the section Synthetic biology and its possible applications in 
Streptomyces bacteria (Zotchev et al., 2012; Rebets et al., 2014; Yoon and Nodwell, 2014).   
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2. Molecular regulation of antibiotic biosynthesis in Streptomyces venezuelae 
As it was mentioned before, S. venezuelae produces two antibiotics – chloramphenicol and 
jadomycin. While first one is produced in standard conditions, jadomycin biosynthesis is 
induced through environmental stress factor like for example 6% ethanol addition in culture 
medium. In order to control this mechanism in an efficient way, S. venezuelae developed very 
efficient regulatory system of cross-regulation in an antagonistic mode.  Jadomycin cluster is 
consisted of five regulatory genes: jadW1,-W2,-W3,-R2, and -R1 (Wang et al., 2009). Main 
molecules which govern its regulation are JadR1 and JadR2. jadR1 is located upstream of 
jadJ which comprises first structural gene from jadomycin biosynthesis cluster. It contains 
winged-like helix-turn-helix motif at C-terminal output domain and two aspartic acid residues 
substituted by Glu49 and Ser50 in N-terminal receiver domain (Liu et al., 2013). In addition 
to that, JadR1 is an OmpR-type ARR (“atypical” response regulator). This means that it is a 
part of two-component transduction system, typically comprised from sensor histidine kinase 
and cognate response regulator. It is described as “atypical” due to decreased number of 
conserved residues in N-terminal receiver domain. Interestingly, determinants of such systems 
are located in a considerable distance from their histidine kinase gene (Wang et al., 2009).  
Regulatory genes jadW1, jadW2 and jadW3 appear to exert very strong amino acid sequence 
similarity when compared to gene products connected with regulation of morphological 
differentiation as well as secondary metabolism through γ-butyrolactones in many 
Streptomyces species (Kharel et al., 2011).  
In order to start biosynthesis from the cluster, JadR1 has to sense signalling molecules. It 
occurs due to the fact that JadR1 can’t be phosphorylated. When concentration of jadomycin 
B is low in the environment, JadR1 activates the expression of the antibiotic from the cluster. 
On the contrary however, high concentration causes JadR1 to dissociate from target promoter. 
Concluding, activation of the jadomycin cluster is autoregulated in dose-dependent manner. In 
addition to that, it appears that JadR1 is involved at the same time in repression of 
chloramphenicol by binding to an extended sequence in this antibiotic cluster. Place of 
binding is located downstream to the transcription start site of cmlJ.  
jadR2 which is a gene adjacent to jadR1 inhibits its transcription. As a result, during the 
repression of JadR1 by JadR2, chloramphenicol biosynthesis is turned on. In order to release 
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JadR1, jadomycin or chloramphenicol has to bind to JadR2.  This makes JadR2 to have a role 
of biosensor. Same effect can be obtained by ethanol shock mentioned in the previous 
paragraph. Unfortunately mechanism behind this phenomenon was not elucidated yet. Finally, 
accumulation of JadR1 leads to repression of chloramphenicol and activation of jadomycin 
synthesis. In the case of deletion mutant with jadR2, jadomycin B expression is switched on 
in the absence of normally, compulsory stress factors. On the other hand, production of 
chloramphenicol is repressed at the same time (Liu et al., 2013).   
 
 
 
Figure 5. Scheme presenting cross-coordination of different antibiotic biosynthetic 
pathways in S. venezuelae (Liu et al., 2013). 
 
Table 2. Jadomycin B biosynthetic genes and proposed functions (Kharel et al., 2011). 
Gene Function Gene Function 
jadW1 Regulator jadK Hydrolase 
jadW2 Regulator jadL Efflux pump 
jadW3 Regulator jadM 2 Phosphopantetheinyl 
transferase 
15 
 
jadR2 Transcriptional reg. jadN Malonyl-coenzyme 
A decarboxylase 
jadR1 Transcriptional reg. jadX Unknown 
jadJ 2 Acetyl-coenzyme A 
carboxylase 
jadO NDP-hexose-2,3-
dehydratase 
jadI Cyclase jadP NDP-hexose-3-
ketoreductase 
jadA1 Ketoacyl synthase jadQ NDP-glucose 
synthase 
jadB1 Chain length factor jadS Glycosyltransferase 
jadC1 Acyl carrier protein jadT NDP-hexose-4,6-
dehydratase 
jadE1 Ketoreductase jadU NDP-hexose-5-
epimerase 
jadD1 Cyclase/Dehydratase jadV NDP-hexose-4-
ketoreductase 
jadF Oxygenase/Dehydratase jadR* tetR homologue 
jadG Anthrone oxygenase jadY Unknown 
jadH Oxygenase/Dehydratase jadZ Unknown 
 
1PKS genes 
2genes required for biosynthesis of jadomycin B 
 
3. γ-butyrolactones 
γ-butyrolactones are signalling molecules in Streptomyces regulating secondary metabolism 
and morphological differentiation. They belong to a family of TetR regulators. They are 
synthesized in big amounts just before the growth of the organism is stopped (Wang et al., 
2003). They exist in a form of ligand and cognate to it receptor. Most receptors belong to 
repressor proteins family. Mechanism of inhibition involves binding to receptor protein which 
resides in cytoplasm. Since binding of one target molecule is retarded, expression of the other 
is turned on (Takano, 2006). By this means they can have a significant role in cross-regulation 
between various antibiotic pathways (Wang et al., 2003). γ-butyrolactones molecules are 
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common for Streptomyces but they vary significantly between species. Some researchers refer 
to them as “pseudo” γ-butyrolactones due to the fact that on the contrary to genuine receptors, 
which bind only to specific γ-butyrolactones molecules, they act as signal coordinating 
antibiotic biosynthesis by binding and responding to different antibiotics. In this way, 
antibiotics facilitate intracellular signalling and induce downstream responses. In several 
publications they are said to resemble quorum sensing molecules. By definition, quorum 
sensing is a way for bacteria to translate their population density into cellular responses (Xu et 
al., 2010). As it was mentioned before jadR1 and jadR2 are involved in regulation of 
jadomycin synthesis. JadR1 has a role of cluster-situated regulator, while JadR2 is a pseudo γ-
butyrolactone receptor. Research has proved involvement of few more genes from the same 
cluster. These are jadW1, jadW2 and jadW3.  Especially jadW1 turned out to be one of a 
major importance (Wang et al., 2009). It is said to resemble by sequence afsA which encodes 
a key element for widely characterized A-factor synthesis found in many Streptomyces 
species (Bibb, 2005). Moreover, inactivation of jadW1 has the influence on both antibiotic 
production and morphology. If jadW1 is lost, S.venezuelae is no longer able to produce 
neither jadomycin nor chloramphenicol. However, when the gene is restored, production of 
jadomycin in mutant strain is increased 2.5 fold. The reason for that might be presence of 
several copies of jadW1 gene due to multiple chromosomal integrations by shuttle vector. It is 
appears that jadR2 codes for pseudo γ-butyrolactone which represses the expression of jadW1 
(Zheng et al., 2007; Kharel et al., 2011; Liu et al., 2013).  jadR2 through binding to the 
promoter region of jadW1 which is coding for putative γ-butyrolactone synthase, directly 
shuts down its transcription. Summing up, JadR2 has two binding sites: one in the promoter 
region of jadR1 and the other in jadW1 (Wang and Vining, 2003).  
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IV. Synthetic biology and its possible applications in Streptomyces 
bacteria 
In 1974, Polish geneticist Wacław Szybalski presented for the first time novel term of 
synthetic biology. Until the year 2004, when the international meeting on synthetic biology 
was held at MIT (USA), it did not gained much of popularity.  Just after this event, synthetic 
biology slowly found its place in mainstream science and gained the belief of tremendous 
positive impact on future biotechnology prospects. By the definition, it is a multidisciplinary 
science joining together fields like genetics, nanotechnology, chemical engineering, robotics, 
system biology. Main characteristics comprise connecting basic elements of the cell which 
regulate the operational functionality of the microorganism to design, engineer and build new 
synthetic entities as well as re-engineer already existing ones. It aims to give the cells new 
properties and characteristics which may turn out to be beneficial for industrial application. 
Current synthetic biology focus evolves mainly around therapeutics, biofuel production and 
bioremediation (Jain et al., 2012).  This chapter is committed for the review of some of the 
synthetic biotechnology approaches available up-to-date, with the highlights of the methods 
employed for the purposes of this thesis. 
1. Modern methods of cloning 
One of the important tools in synthetic biology are methods for DNA assembly which like the 
field itself are still relatively new. They aim to reconstruct natural pathways but also make 
new ones. Methods may be classified into those based on the homology and ligation.  
Approaches based on the homology require that the neighbouring DNA fragments possess an 
identical sequences which allows for splicing to happen by homologous recombination in vivo 
or extension of the homologous ends in vitro.  
Gibson assembly which was used in this master thesis is a method where DNA fragments 
containing homologous ends are joined together by three enzymatic reactions. Benefits of this 
approach are scarless, mostly sequence-independent and multi-part method allowing for one-
tube isothermal reaction with big assemblies up to 300 kb. Limitations are quite expensive 
enzyme mix, parts smaller than 250 bp seems not suitable and secondary structures especially 
in the case of strains with high G+C content of the genome may impede DNA assembly. 
Details can be found in the Materials and Methods section. 
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Sequence and ligase independent cloning also referred as SLIC similarly to Gibson exploits 
3’exonuclease and T4 DNA polymerase ability to chew-back 3’ ends and fill the gaps. It is 
also a scarless and mostly sequence and ligase-independent reaction but allows only for 
assembly constructs up to 20 kb. Same like in the case of Gibson, secondary structures may 
inhibit the acquisition of final product. 
PIPE stands for polymerase incomplete primer extension cloning. Its main principle is based 
on keeping single-stranded 3’ ends by incomplete primer elongation during PCR cycle. 
Uracil-specific excision reagent cloning (USER) creates single-stranded 3’ ends by 
involvement of both uracil-containing primers and uracil-specific glycosylase and 
endonuclease. 
With the exception of Gibson, none of the above approaches use ligase. Its function is 
replaced by nick-sealing in vivo which happens after the construct in transformed in the host 
of interest. In addition to that, SLIC and PIPE undergo in vivo also gap-filling process.  
CPEC stand for circular polymerase extension cloning. Parts of assembly with homologous 
ends undergo cycles of denaturation, annealing and extension in order to form duplexes which 
after many cycles are joined together in vivo. 
Site-specific recombination-based tandem assembly (SSRTA) uses Streptomyces phage φBT1 
for joining the fragments together. Reaction takes place in vitro and flanking of the fragments 
by a set of orthogonal recombination sites are necessary. For that reason, it leaves scars which 
may present significant constrain. Despite of this disadvantage, method offers high specificity 
of φBT1 integrase and removal of polymerase extension step which avoids introducing 
mutations. 
DNA Assembler is a technique which involves S. cerevisiae as a host for the assembly 
reaction of DNA fragments with overlapping, homologous, terminal sequences. Reaction 
allows for assembly and transformation in one reaction as well as selection of the homologous 
recombinant by incorporation of a specific marker.  
Interestingly, another in vivo assembly example is Red recombination system, where 
amplification of homologous recombination in E. coli is caused by expression of Redαβ 
proteins from lambda prophage or RecET proteins from Rac prophage. 
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Mating-assisted genetically integrated cloning which is referred as MAGIC takes advantage 
of bacterial conjugation in order to transfer donor plasmid to the hosts’ strain receiver 
plasmid. In order to generate linear fragments and enhance homologous recombination 
endonuclease and lambda recombinases are supplemented. 
SLiCE stands for seamless ligation cloning extract which is a technique providing benefits of 
cheap, scarless, one-tube reaction which is in most of the cases sequence-independent and 
ensures high fidelity. Unfortunately, it has not been tested neither for big (more than 4kb), 
multi-part nor high G+C DNA assembly content.  
In order to standardize cloning techniques which is one of the goals of synthetic biology, 
several ‘genetic devices’ were designed. 
BioBrick assembly is one of the examples. Underlying principle is based on the restriction 
digest and ligation reaction to be conducted at the same time. This leads to removal of 
recognition sites in between the fragments but retaining those at their ends. Assembly has 
wide range of varieties, is cheap and simple and it is performed with the help of commercial 
kits. Drawbacks of the method are scars in the sequence and time consuming assembling 
process due to the possibility of joining only two pieces at the time.  
Another approach based on the use of restriction enzymes is Golden Gate assembly and its 
variants. It employs type IIS restriction endonucleases which are able to bind specific 
recognition sites but cut in the significant distance from it. Method is quasi-scarless, offers 
multi-part assembly where homology of the parts is not a requirement. It is important to mark 
however that internal sites for the restriction enzymes should be eliminated (Zotchev et al., 
2012; Cobb et al., 2014).   
Assembly of bigger constructs turns out to be successful in yeast which was proved by the 
results in this thesis. Biosynthetic gene cluster assembly in yeast followed by transfer to 
Streptomyces host and subsequent heterologous expression was one of objects of 
investigation.  
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Figure 6. Modern techniques for multi-part DNA assembly (Cobb et al., 2014). 
2. Reporter genes  
Reporter markers are used in a bacterial genetics to study processes like gene regulation, gene 
expression activity, translation and transcription of operons, gene improvement and more. 
Their function is to visualize various biological processes in living cells. Reporter genes 
available in Streptomyces are: neo (encoding neomycin phosphotransferase), cat (encoding 
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chloramphenicol acetyltransferase), xylE (encoding catechol 2,3-dioxygenase), green 
fluorescent protein, luciferase, gusA (Myronovskyi et al., 2011; Siegl and Luzhetskyy, 2012). 
Marker genes facilitate production and subsequent identification of transgenic organisms. 
Two groups of marker genes exist: selectable marker genes and nonselectable – also called 
scorable marker or reporter genes. Among selectable markers, researchers distinguish two 
groups: positive – which include giving a selective advantage to a cell and negative which 
means selective killing (Stewart, 2008). Since gusA was used during the development of this 
master thesis, it will be described below.  
gusA gene encodes for β-glucuronidase enzyme in E. coli. When fused to regulatory 
sequences or introduced into biological system, it generates a signal which may be quantified. 
Detected signal is directly correlated with the activity of promoter (Ramakrishna, 2009). In 
this way, it is possible to assess influence of various factors affecting the cell like for instance 
stress or trans-acting factors. These factors modulate expression at transcriptional or 
translational level. These changes are possible to detect thanks to advantage of reporter 
markers. 
There are several advantages of using GUS (gusA) reporter system. Benefits arise from the 
stability of the enzyme which does not require any cofactors and also high specific activity 
which makes it very sensitive. In addition, β-glucuronidase is unusually tolerant to most used 
chemicals and conditions in the assay like pH and temperature. Conveniently, most of the 
Streptomyces strains have been found to lack β-glucuronidase endogenous activity. Summing 
up, assay is relatively simple, inexpensive and sensitive. It also exists in a wide range of 
commercially available substrates for various assay types and formats like: 
spectrophotometric, fluorimetric, chemiluminescent, chromogenic (Myronovskyi et al., 2011). 
3. Heterologous expression of natural product biosynthetic gene clusters 
Heterologous expression is one of the approaches of genome mining technique. As it is 
described by Gomez-Escribano and Bibb (2013), genome mining is “the use of 
bioinformatics, molecular genetics, and natural product analytical chemistry to access the 
metabolic product of a gene cluster found in the genome of an organism”. Genome mining 
may be employed in two ways. Firstly, by activating the silent gene cluster either by 
manipulation involved with deletion or over-expression of negative or positive transcriptional 
regulators, respectively. An alternative method consists of cloning the fragment of DNA of 
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producing microorganism along with gene cluster of interest and attempt to express it in 
suitable host. Heterologous expression applications are connected with confirmation of 
complete transfer of genes from the cluster of interest, attempt of acquisition metabolic 
product from cryptic gene cluster or difficult to culture or not genetically amenable organism, 
obtaining unnatural metabolites or expressing mutated gene clusters. Hosts like E. coli, S. 
cerevisiae or several Streptomyces species are used for these purposes. Advantage of E. coli 
host is a wide range of possible vectors and promoters and opportunity to express genes with 
G+C sequence as high as 73%. Drawbacks include inability of recognition of promoters 
originating from Streptomyces, lack of production of some precursors which are necessary for 
biosynthesis of compounds and frequent incorrect folding of type I polyketides synthase 
proteins. Successful attempts of initial cloning of selected genes in E. coli vectors which bear 
yeast promoters and then subsequent assembly and expression in YAC system resulted in 
production of several flavonoids. However, in order to achieve that expression, in most of the 
cases genetic engineering modifications are required. The odds for sustainable expression 
increase if the source genes and the host strain are closely related to each other. The ideal 
Streptomyces host for synthetic biology purposes should posses following, desirable 
characteristics. Firstly, it should offer a wide range of vectors and markers. In addition, it was 
proved that removal or limited production of all endogenous, active secondary metabolite 
gene clusters is an advantage. In this way, chances of interfering with the activity of target 
gene cluster are significantly decreased. Pathways for biosynthesis should be well understood. 
Catabolic pathways should utilize cheap nutrients in order to ensure financial sustainability. 
Strain should easily accumulate biomass without losses in productivity. More than that 
efficiency of cluster cloning is another difficult step. Heterologous expression may turn out to 
be useful, when natural producer fails to provide sufficient titers of metabolite allowing for 
researching its biosynthetic pathway (Zotchev et al., 2012; Gomes-Escribano and Bibb, 2014)  
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V. The aims of this study 
The aim of this study was to re-engineer the antibiotic biosynthesis regulatory circuit in  
S. venezuelae in order to evoke inducible heterologous production of secondary metabolites, 
using jadomycin and chloramphenicol as models. This was planned to be achieved by 
exchange of the promoter which drives expression of the cml structural genes. Since these 
genes are under repression of JadR1 regulator, it was thought to be sustainable to substitute 
the cml promoter with a promoter which is activated by JadR1. In this way, upon ethanol 
shock, instead of jadomycin production, chloramphenicol biosynthesis would take place. The 
specific goals to reach overall aim were: 
1. Deletion of jadJ-E structural genes from S. venezuelae chromosome and replacement 
with a reporter gene gusA 
2. Testing gusA expression upon ethanol shock 
3. In case the expression of a reporter is shown to be dependent on the ethanol, replacing 
cmlI-X promoter in deletion mutant with jadR1-jadJ promoter region in the 
chloramphenicol biosynthetic gene cluster   
4. Testing the recombinant strain for dependence of chloramphenicol production on 
ethanol stress 
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Materials and Methods 
Four constructs were planned to be constructed throughout the span of this master thesis.  
1. pJP1 – construct for deletion of of jadJ-E genes in S. venezuelae  
2. pJP1gusA – construct for deletion of of jadJ-E genes in S. venezuelae with 
another version of  gusA region  
3. pJP2 – construct for replacement of the cmlI promoter in S. venezuelae with jadJ 
promoter 
4. pCML3 – construct for  heterologous expression of chloramphenicol antibiotic 
gene cluster 
Labwork was performed according to the flowcharts and detailed description presented 
below. Boxes marked orange are common for all the charts; blue ones are distinct for the 
particular workflow.  
Need for exchange of gusA fragment from the initial construct i.e. pJP1 arose from the fact of 
discovery a mutation preventing gusA from correct functioning. For that reason pJP1gusA 
construct appeared.  
All the procedures described in the following sections can be found in Lab protocols chapter 
of this master thesis.  
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pJP1 construct fragments were initially amplified by PCR (description: Lab protocols, PCR 
amplification, PCR I). After this step 2µl of the product was used to perform gel 
electrophoresis and the rest was subsequently purified. Afterwards, 2µl purified product was 
once more checked on the gel. Conditions: 55min, 100V. Vector was treated with DpnI in 
order to get rid of the template residues.  
Yeast transformation using protocol for ‘Yeast Transformation by LiAc/SS Carrier DNA/PEG 
Method’ was subsequently employed. Fragments were mixed in the following volumes: 
vector - 3µl, left flank – 3µl, right flank – 3µl, gusA – 4µl, water – 21µl. Resulting colonies 
were picked up for overnight incubation, and  next day DNA was isolated. DNA from the 
yeast clones was electroporated to E. coli DH5α. DNA from colonies was isolated and 
analysed by restriction cutting with BamHI in order to determine whether the correct 
assembly was constructed.  
After successful confirmation, DNA was transformed to E. coli ET12567 cells and plated on 
LA plates supplemented with Am100, Cml25 and Kan25. ET12567 clones were afterwards 
conjugated to S. venezuelae WT. Obtained colonies were preliminarily screened on ISP4 
medium with Nal30 and Am50 and incubated at 30ºC until visible growth appeared. TSB 
supplemented with Nal30 and Am50 was inoculated for overnight incubation at the same 
temperature, DNA isolated and checked by PCR. 
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I. Flowchart of labwork for the construct pJP1. 
 
Transformation 
to E. coli DH5α 
DNA isolation form 
yeast clones 
Colonies picked up for overnight 
incubation at 30ºC in liquid 
SCM 
Yeast 
transformation 
PCR 
amplification 
PCR product 
purification 
DpnI treatment 
of the vector 
Transfer of 2.5ml inoculum to 50ml 
2xYPAD; overnight incubation at 30ºC 
for approximately 4 hours. 
Inoculation of S.cerevisiae into 3ml 
YPAD broth and inoculation overnight 
at 30ºC. 
Restriction 
analysis 
DNA isolation 
from the clones 
Colonies picked up for overnight 
incubation at 37ºC in LB Am100 
Transformation to 
E. coli ET12567 
Conjugation to 
S.venezuelae WT 
Plating of the clones to the LA 
plates supplemented with Am100, 
Cml25 and Kan25 
Inoculation of the ISP4 
plate with 
S.venezuelae WT, 
incubation for 3-4 days 
in 30ºC until reaching 
confluent plate 
Picking up colonies to plates ISP4 
supplemented with Nal30 and Am50; 
incubation in 30ºC for few days 
Overnight 
incubation at 30ºC 
in 2ml TSB 
supplemented with 
Nal30 and Am50 
DNA isolation 
from S.venezuelae 
transconjugants 
PCR check 
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As it was mentioned previously, pJP1gusA construct was assembled in order to exchange 
mutated gusA gene in pJP1. Fragments were amplified by PCR (description: Lab protocols, 
PCR amplification, PCR IV), purified and checked on the agarose gel following each of those 
two steps. gusA fragment was amplified using pSOK808 template. Subsequently, vector was 
treated with DpnI.  
Fragments were mixed and assembled using Gibson assembly method in following ratio: 
4.5µl GusA, 0.5µl vector. Gibson mix was later on transformed to couple of potential hosts 
like E. coli DH5α, G10 Elite, XL1-Blue and E. cloni 10G. DNA from the transformants was 
isolated and restriction analysis with several enzymes like BamHI, PstI, AseI, MluI was 
performed. After several attempts, no right construct was obtained and due to the time 
constrains this part of the project was not continued.  
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II. Flowchart of labwork for the construct pJP1gusA. 
Pathway identical like 
this marked orange for 
construct pJP1 
Picking up colonies to plates ISP4 
supplemented with Nal30 and Am50; 
incubation in 30ºC for few days 
Overnight 
incubation in 2ml 
TSB supplemented 
with Nal30 and Am50 
DNA isolation 
from S.venezuelae 
transconjugants 
PCR check 
GUS assay 
Restriction 
analysis 
DNA isolation 
from the clones 
Transformation to 
E. coli ET12567 
Conjugation 
Plating of the clones to the LA 
plates supplemented with Am100, 
Cml25 and Kan25 
Inoculation of the 
ISP4 plate with  
S. venezuelae WT, 
incubation for 3-4 
days in 30ºC until 
reaching confluent 
plate 
PCR 
amplification 
PCR product 
purification 
DpnI treatment 
of the vector 
Gibson 
Assembly 
Transformation to E. coli DH5α, G10 
Elite, XL1-Blue or E.cloni 10G  
Colonies picked up for overnight 
incubation at 37ºC in LB Am100 
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Fragments for pJP2 assembly were amplified by PCR (description: Lab protocols, PCR 
amplification, PCR II), checked on the gel, purified and checked on the gel for the second 
time. Vector was DpnI treated. Assembly using ‘Yeast Transformation by LiAc/SS Carrier 
DNA/PEG Method’ was performed. Fragments were mixed in following ratio: vector - 1µl, 
left flank - 3µl, right flank - 3µl, promoter region - 8µl, water 18µl. Colonies resulting from 
this transformation were inoculated overnight at 30ºC to liquid SCM and DNA was isolated 
the following day. Plasmid DNA isolated from yeast cells, have been transformed into E.coli 
strain. After isolation of the DNA from the transformants, it was analysed by restriction digest 
and checked on the gel.  
Correct clone was introduced to E. coli ET12567 cells., and selected on LA with Am. 3 clones 
were plated onto LA Am100, Cml25 and Kan25 plates, and one of them subsequently subjected 
to intergeneric conjugation with S. venezuelae WT.  
Resulting transconjugants were checked using PCR method and after this confirmation test, 
selection for the second crossover took place. It was performed by three-day series of 
overnight incubations at 30ºC in 2 ml TSB without antibiotics. Dilution 10-6 from the culture 
was plated in 100µl aliquotes over 20 ISP4 plates in order to get single colonies.  Plates were 
incubated at 30ºC for 2-3 days until visible growth appeared.  
Following this, replica plating technique was employed. Sterile velvet pads were placed over 
the wooden stamp and pressed to ISP4 plates, and then gently pressed in the same position to 
ISP2 plates supplemented with Am50. After few days results of selection were visible. Plates 
were compared with each other. Successful potential second-crossover colonies were able to 
growth on ISP4 but lost the ability to grow in the presence of apramycin. Genomic DNA from 
the candidates for second crossover was isolated and checked using PCR and restriction 
cutting with HindIII.  
Assessment of chloramphenicol production from the recombinant strain was performed. 1 ml 
out of 3 ml overnight TSB culture at 30ºC of pJP2 in S. venezuelae was used to inoculate 30 
ml of MYM medium and incubate it for 9h at 30ºC. After this time, culture was divided in 
two flasks 15 ml each. One of them was supplemented with 1 ml 96% ethanol. At the same 
time 1ml of purified water was added to the other flask which comprised the control. Cultures 
were incubated for further 48h in the same conditions. Subsequently chloramphenicol was 
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extracted using ethyl acetate method. Results were assessed by UPLC analysis. Control with 
S. venezuelae WT was conducted alongside to the recombinant strain. Results from the UPLC 
analysis of both strains were compared to each other. 
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III. Flowchart of labwork for the construct pJP2. 
 
 
 
 
 
 
  
DNA isolation 
Restriction analysis 
1st round: Inoculation of 
2ml TSB for 30ºC 
2nd round: Inoculation 
(100µl) of 2ml TSB 
with the previous day 
culture for 30ºC 
overnight 
3rd round: Inoculation 
(100µl) of 2ml TSB 
with the previous day 
culture for 30ºC 
overnight 
Dilution of the culture 
to 10-6 and plating on 
20 ISP4 plates; 
incubation for 2-3 days 
at 30ºC 
Comparison of the 
growth 
Printing on ISP2 Am50 
plates; incubation for 2-3 
days at 30ºC 
PCR check of the clones 
as a result confirmation 
Pathway identical like 
this marked orange for 
construct pJP1 
Picking up colonies to plates ISP4 
supplemented with Nal30 and Am50; 
incubation in 30ºC for few days 
Assessment of 
chloramphenicol 
production  
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Similarly to other constructs, fragments for pCML3 were amplified by PCR (description: Lab 
protocols, PCR amplification, PCR III), 2µl of DNA were checked on the agarose gel, and 
product was purified and once more checked by electrophoresis. DnpI treatment of the vector 
was performed.  
As it was also mentioned in the other descriptions, this construct was also assembled by yeast 
transformation with LiAc/SS Carrier DNA/PEG. DNA fragments were mixed by following: 
vector - 3µl, Cml3H1 - 3µ, Cml3H2 - 6µl, water - 22µl. Plasmid DNA was isolated from 
yeast clones and transformed into E. coli strain to check the assembly. Plasmid DNA from  
E. coli was cut by EcoRI and PvuII to find the correct clones.  
Transformation to E. coli ET12567 and plating of the resulting colonies on the plates with the 
addition of Am100, Cml25 and Kan25 was a pre-step for intergeneric conjugation to S. albus. 
Similarly to S. venezuelae, transconjugants of S. albus were checked both by plating on the 
SFM plate with Nal30 and Am50 and also with PCR amplification and subsequent agarose gel. 
After confirmation of the correct constructs, S. albus transconjugants were incubated 
overnight in 2ml TSB at 30ºC. On the very next day, 50ml PM4-1 and NZA media were 
inoculated with 500µl of the overnight culture and incubated in the same conditions at the 
shaker for next 7 days. After this time, chloramphenicol was extracted using method 
involving ethylacetate. Results were analysed externally by UPLC analysis.  
 Complementation experiment 
It was performed in order to check if the introduction of construct pCML3, containing the 
whole cml cluster, is able to restore the production of Cml in JadRI/CmlΔ mutant, non-
producer of Cml. Double deletion S. venezuelae mutant was provided - JadRI/CmlΔ. It was 
conjugated with pCML3. Transconjugants were selected by plating them on ISP4 medium 
with Nal30 and Am50 and then confirmed PCR amplification and electrophoresis analysis.  
Similarly to the previous assembly, 2ml TSB was inoculated by spores from the 
complementation strain for overnight incubation at 30ºC. 500µl of overnight culture was used 
to start the 7 days fermentation in 50 ml PM4-1 in shaking incubator at 30ºC. After 7 days, 
chloramphenicol was extracted using method with ethylacetate. In order to assess the amount 
of the antibiotic in the cultures, samples were sent for UPLC analysis.
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IV. Flowchart of labwork for the construct pCML3. 
 
 
Inoculation of 50ml PM4-1 and 
NZA with 500µl overnight 
culture; incubation for 7 days at 
30ºC  
Overnight incubation in 2ml TSB 
supplemented with Nal30 and 
Am50 at 30ºC 
Assessment of chloramphenicol 
production by UPLC 
Conjugation 
Pathway identical like 
this marked orange for 
construct pJP1 
Plating of the clones to the LA 
plates supplemented with Am100, 
Cml25 and Kan25 
Inoculation of the 
SFM plate with 
S.albus WT, 
incubation for 3-4 days 
in 30ºC until reaching 
confluent plate 
Picking up colonies to plates SFM 
supplemented with Nal30 and Am50; 
incubation in 30ºC for few days 
Overnight 
incubation in 2ml 
TSB supplemented 
with Nal30 and Am50 
DNA isolation 
from S.albus 
transconjugants 
PCR check 
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1. Flowchart of the complementation experiment 
Picking up colonies to plates ISP4 
supplemented with Nal30 and Am50; 
incubation in 30ºC for few days 
Overnight 
incubation in 2ml 
TSB supplemented 
with Nal30 and Am50 
DNA isolation 
from S.albus 
transconjugants 
PCR check 
Conjugation 
Plating of the E. coli ET12567 
clones from pCML3 construct to 
the LA plates supplemented with 
Am100, Cml25 and Kan25 
Inoculation of the 
ISP4 plate with 
S.venezuelae 
JadRI/CmlΔ, 
incubation for 3-4 
days in 30ºC until 
reaching confluent 
plate 
Inoculation of 50ml PM4-1 
with 500µl overnight culture; 
incubation for 7 days at 30ºC  
Overnight incubation in 2ml 
TSB supplemented with 
Nal30 and Am50 
Assessment of chloramphenicol 
production by UPLC 
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Table 3. Bacterial strains and plasmids used in this thesis 
Strain or plasmid Characteristics/genotype 
Reference or 
source 
Streptomyces strains   
S. venezuelae 
ATCC 10712 
 
wild-type strain, producer of jadomycin and 
chloramphenicol 
Doull et al., 
1993 
S. venezuelae 
JadRI/CmlΔ 
 
chloramphenicol deleted from jadR1Δ mutant 
genome (second crossover) 
 
Jianhai 
Zhang, 
unpublished 
S. albus J1074 
 
S. albus G1 (DSM 41398) derivative with the 
defective SalGI restriction modification system 
heterologous host 
Myronovskyi 
et al., 2014 
E.coli strains   
DH5α 
 
supE44 ΔlacU169 recA1 endA1 gyrA96 thi-1 
relA1 
 
Reisner et al., 
2003 
ET12567 
(pUZ8002) 
 
 
 
Methylation deficient strain - dam-, dcm-, hsdM- 
which contains helper plasmid pUZ8002 
facilitating conjugative DNA transfer from RP4 
oriT 
 
MacNeil et 
al., 1992 
XL1-blue 
 
 
 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIqZ∆M15 Tn10 (Tetr)] 
Stratagene 
Technical 
Services, 
2004 
E. cloni 10G 
 
 
 
F - mcrA ∆(mrr-hsdRMS-mcrBC) endA1 recA1 
φ80dlacZ∆M15 ∆lacX74 araD139 ∆ (ara,leu) 
7697 galU galK rpsL (StrR) nupGλ tonA 
 
Lucigen 
Yeast strains   
S. cerevisiae 
BY4742 
 
Host for TAR-assisted DNA assembly; MATα 
his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0  
 
Risler et al., 
2012 
Plasmids   
pCLY10 
 
ori15A, VWBint, attP, RP4oriT, aac3(IV), 
LEU2, CEN6-ARS4   
 
Sekurova, 
unpublished 
pSOK808 
 
oriColEI, VWBint, attP, RP4oriT, aac3(IV), 
ermEp*::gusA 
Zotchev, 
unpublished 
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pUC57 –gusA 
 
oriColEI, bla, gusA Zotchev, 
unpublished 
pJP1 ori15A, RP4oriT, aac3(IV), LEU2, CEN6-
ARS4, jadJp::gusA   
 
This work 
pJP1gusA ori15A, RP4oriT, aac3(IV), LEU2, CEN6-
ARS4, jadJp::gusA  (fixed) 
 
This work 
pJP2 ori15A, RP4oriT, aac3(IV), cmlIp->jadJp 
 
This work 
pCML3 pCLY10::cml 
 
This work 
 
V. Lab protocols 
1. DNA isolation 
A. DNA isolation from bacterial cultures 
Procedure was performed according to the instruction for use of products from technical 
bulletin of Wizard® Plus SV Minipreps DNA Purification System.  
1) 2ml of the overnight bacterial culture was harvested by centrifugation for 5 minutes at 
10,000 x g in a tabletop centrifuge. Subsequently supernatant was discarded and tubes 
blotted on a paper towel to remove excess media. 
2) 250µl of Cell Resuspension Solution was added to the samples. Pellet was completely 
resuspended by pipetting in a 1,5ml microcentrifuge tubes. 
3) 250µl of Cell Lysis Solution was added to the samples and mixed by pipetting until 
partial clearing of the lysate was achieved (no more than 5 minutes). 
4) 10µl of Alkaline Protease Solution was added. Tubes were mixed by inverting 4 times 
and afterwards incubated for 5 min in room temperature. Due to the risk of nicking the 
plasmid DNA due to the protease activity 5 min was never exceeded. 
5) 350µl of Wizard® Neutralization Solution was added and tubes were immediately 
mixed by inverting 4 times. 
6) Bacterial lysate was centrifuged at maximum speed (13,000 x g) in a microcentrifuge 
for 10 min at room temperature.  
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7) Cleared lysate was transferred to prepared beforehand Spin Columns. In case white 
precipitate was still present in the lysate, samples were centrifuged additionally for 
another 5 to 10 minutes. 
8) After applying supernatant to the column, tubes were centrifuged at maximum speed 
for 1 min at room temperature. Flowthrough was discarded and columns were 
reinserted to Collection Tubes. 
9) 750µl of Column Wash Solution was applied on the column. Solution was diluted with 
95% ethanol prior to use according to producer description on the package. 
10) Tubes were centrifuged for another 1 min at maximum speed at room temperature. 
Flowthrough was discarded and columns were reinserted into Collection Tubes. 
11) Procedure has been repeated with 250µl of Column Wash Solution. 
12) Subsequently probes were centrifuged at maximum speed for 2 minutes at room 
temperature. 
13) Spin Columns were transferred to new 1,5ml microcentrifuge tube avoiding accidental 
transfer of any residual Column Wash Solution.  
14) Plasmid DNA was eluted with 30 or 50µl of Elution Buffer applied to the centre of 
membrane depending from expected DNA yield. 
15) Samples were centrifuged at maximum speed for 1 min at room temperature. 
16) Spin Columns were discarded and purified samples later on used for another tests or 
stored frozen in -20ºC. 
 
B. DNA isolation from yeast cultures 
This protocol is based on the previous one i.e. DNA isolation from bacterial cultures. Due to 
the nature of the organism which DNA is isolated from, certain modifications have been 
applied.  
1) 3ml of the overnight yeast culture in SCM medium was harvested by centrifugation 
for 5 minutes at 10,000 x g in a tabletop centrifuge. Subsequently supernatant was 
discarded and tubes blotted on a paper towel to remove excess media. 
2) 250µl of Cell Resuspension Solution mixed with 3µl of Zymolyase were added to the 
samples. Pellet was completely resuspended by pipetting in a 1,5ml microcentrifuge 
tubes.  
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3) Samples were incubated for 1hour in 37ºC. Probes were tipped every 20 min 
throughout the whole time of incubation in order to ensure even distribution of the 
enzyme. 
4) Rest of the steps starting from the step number 3 were followed according to the 
protocol number A i.e. DNA isolation from bacterial cultures. 
 
C. DNA isolation from S.venezuelae 
DNA from Streptomyces was isolated using Dneasy tissue kit from QIAGEN.  Protocol was 
supplemented by the manufacturer, and was modified in our group for isolation of genomic 
DNA specifically from streptomycetes. 
1) Inoculated spores from well-sporulated colonies incubated overnight in 2 ml TSB 
medium were prepared.  
2) 1 ml of the culture was transferred into another eppendorf tube. In addition 0.5 ml of 
sterile water was supplemented. Samples were mixed thoughrouly and spinned down 
for 3 min at 13,000 rpm. Supernatant was discarded, probes were centrifuged shortly 
again, and later on the rest of the cultivation media was removed. 
3) Pellet was resuspended by adding180µl of Lysis Buffer and pipetting the solution up 
and down several times. Lysis Buffer contains 20mM Tris HCl, pH 8.0; 10mM EDTA 
pH 8.0; 1.2% Triton X100; 20 mg/ml lysosyme. Lysosyme was added to earlier 
prepare pre-lysis mix just before the experiment.  
4) Mixed was incubated for 15 min at 37ºC. During this time, samples were tipped every 
5 min. 
5) After the incubation 25µl of Proteinase K was added and mixed by pipetting. Later on, 
200µl of buffer AL was supplemented and mixed by pipetting several times. 
Suspension was incubated for 30 min at 55ºC. 
6) 200µl of 96% ethanol was added and mixed thoroughly by pipetting. Mixture was 
applied on the column inserted into 2 ml collection tube provided by the producer. 
Solution was centrifuged at 13,000 rpm for 2 min.  
7) Columns were transferred to another 2 ml collection tube and 500µl of AW1 buffer 
was applied. Samples were spinned for 1 min at 13,000 rpm. 
8) Columns were transferred to new 2ml collection tubes and 500µl of AW2 buffer was 
applied. Samples were spinned for 3 min at 13,000 rpm. 
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9) Columns were transferred to new eppendorf tubes and 125µl of previously preheated 
to 50ºC buffer AE was applied onto them. Probes were incubated 15 min at room 
temperature. 
10) Samples were centrifuged for another 1 min at 13,000 rpm in order to elute DNA, 
columns were discarded, and DNA was stored in -20ºC.  
2. PCR amplification 
PCR is an abbreviation from Polymerase Chain Reaction and was invented by Kary Mullis. It 
in an in vitro amplification reaction with a set of enzymes and different temperature steps 
throughout. They comprise three essential for PCR steps: denaturation, annealing and 
extension. During the first one, strands of the DNA template are separated in high temperature 
reaching 94-95ºC. Later in annealing step, by lowering the temperature primers are able to 
attach to their complementary sequences on the template strands. Here, temperature of the 
reaction varies with the respect of the used primers in order to ensure highest possible 
specificity. The higher annealing temperature, highest specificity. In the last step, temperature 
is adjusted to the DNA polymerase activity which facilitates elongation process throughout 
several cycles (McPherson and Moller, 2006). In this master thesis PCR amplification was 
used in following setup: 
PCR Mix 13µl 
Template 1µl 
Primers (forward and reverse) 1µl + 1µl 
Polymerase 1µl 
H2O 8µl 
Total 25µl  
 
Two types of polymerases were used: Expand High Fidelity Polymerase PCR System 3.5 
U/µl from Roche Diagnostics GmbH and MasterAmp™ Extra Long Polymerase Mix 2.5 U/µl 
from Epicentre. PCR mixes were a part of MasterAmp™ Extra-Long PCR Kit. 
PCR I 
1) For jad deletion construct (pJP1) 
a. Setup for vector: 
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PCR Mix Number 1 
Template pCLY10 
Primers (forward and reverse) Y10_SVF1 + Y10_SVR1 
Polymerase Expand High Fidelity 
H2O H2O 
Program: SZLG  
 
b. Setup for left and right flank: 
PCR Mix Number 7 
Template S. venezuelae gDNA 
Primers (forward and reverse) JJEdel-F + R2; JJEdelR-F + R 
Polymerase Expand High Fidelity 
H2O H2O 
Program: SZLG  
 
c. Setup for gusA part: 
PCR Mix Number 7 
Template pUC57 
Primers (forward and reverse) gusAF2 + R2 
Polymerase Expand High Fidelity 
H2O H2O 
Program: SZLG  
 
PCRII 
2) For promoter replacement construct (pJP2) 
a. Setup for vector 
PCR Mix Number 9 
Template pCLY10 
Primers (forward and reverse) Y10_SVcml-F + R 
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Polymerase Expand High Fidelity 
H2O H2O 
Program: SZLG  
 
b. Setup for left and right flank 
PCR Mix Number 7 
Template S. venezuelae gDNA 
Primers (forward and reverse) CmlI-F + R; CmlX-F + R 
Polymerase Expand High Fidelity 
H2O H2O 
Program: SZLG  
 
c. Setup for promoter region amplification 
PCR Mix Number 7 
Template S. venezuelae gDNA 
Primers (forward and reverse) jadJp-F + R 
Polymerase Expand High Fidelity 
H2O H2O 
Program: SZLG  
 
PCR III 
3) Fragments for chloramphenicol assembly with long overlaps (pCML3) 
a. Setup for vector 
PCR Mix Number 9 
Template pCLY10 
Primers (forward and reverse) Y10_cml3-F + R 
Polymerase Master Amp. Polymerase 
H2O H2O 
Program: SZLG2  
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b. Setup for remaining fragments 
PCR Mix Number 7 
Template S. venezuelae gDNA 
Primers (forward and reverse) Cml3H1-F + R; Cml3H2-F + R 
Polymerase Master Amp. Polymerase 
H2O H2O 
Program: SZLG2  
 
PCR IV 
4) For gusA exchange (pJP1gusA) 
a. Setup for amplification of the whole assembly except gusA region 
PCR Mix Number 9 
Template pJP1 (assembly no 1) 
Primers (forward and reverse) Y10_cml3-F + R 
Polymerase Master Amp. Polymerase 
H2O H2O 
Program: SZLG  
 
b. Setup for gusA part 
PCR Mix Number 9 
Template pSOK808 
Primers (forward and reverse) gusA_JP-F + R 
Polymerase Master Amp. Polymerase 
H2O H2O 
Program: SZLG  
 
 Checking of mutant strains by PCR 
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Setup for pJP1 
PCR Mix Number 7 
Template DNA from transconjugant 
Primers (forward and reverse) JJEdel-F + JJEdelR-R 
Polymerase Master Amp. Polymerase 
H2O H2O 
Program: SZLG  
 
Setup for pJP2 
PCR Mix Number 7 
Template DNA from transconjugant 
Primers (forward and reverse) Y10_SVcml-F + R 
Polymerase Master Amp. Polymerase 
H2O H2O 
Program: SZLG  
 
 
PCR Mix Number 7 
Template DNA from transconjugant 
Primers (forward and reverse) CmlI-F + CmlX-R 
Polymerase Master Amp. Polymerase 
H2O H2O 
Program: SZLG  
 
Setup for pCML3 and complementation experiment 
PCR Mix Number 7 
Template DNA from transconjugant 
Primers (forward and reverse) Cml3H1-F + R 
Polymerase Master Amp. Polymerase 
H2O H2O 
44 
 
Program: SZLG  
 
PCR Mix Number 7 
Template DNA from transconjugant 
Primers (forward and reverse) Cml3H2-F + R 
Polymerase Master Amp. Polymerase 
H2O H2O 
Program: SZLG2  
 
As a control DNA from S. venezuelae WT as a template was used. 
All PCR product sizes were simulated in Clone Manager.   
PCR programs 
PCR programs used in this master thesis are specified in the tables below: 
SZLG 
Step Temperature Time [h:m:s] 
Denaturation 95.0ºC 00:03:00 
Continued denaturation 94.0ºC 00:00:45 
Annealing 56.0ºC 00:00:45 
Elongation 68.0ºC 00:10:00 
- Go to 2 rep 25 - 
Continued elongation 68.0ºC 00:10:00 
Hold 4.0ºC ∞ 
 
SZLG2 
Step Temperature Time [h:m:s] 
Denaturation 95.0ºC 00:03:00 
Continued denaturation 94.0ºC 00:00:45 
Annealing 56.0ºC 00:00:45 
45 
 
Elongation 68.0ºC 00:22:00 
- Go to 2 rep 25 - 
Continued elongation 68.0ºC 00:25:00 
Hold 4.0ºC ∞ 
 
OSGIB 
Step Temperature Time [h:m:s] 
Incubation 50.0ºC 01:00:00 
Hold 4.0ºC ∞ 
 
DPNJP 
Step Temperature Time [h:m:s] 
Incubation 37.0ºC 03:00:00 
Inactivation 80.0ºC 00:20:00 
Hold 4.0ºC ∞ 
 
3. PCR product purification 
PCR purification was performed according to the protocol QIAquick PCR Purification Kit 
Protocol using a microcentrifuge from QIAquick® Spin Handbook for QIAquick PCR 
Purification Kit from QIAGEN. Protocol was designed in order to purify single- or double-
stranded DNA fragments from PCR. Procedure allows for removal of primers, nucleotides 
and buffer component as well as nontarget ampliﬁcation products. 
Note: All centrifugation steps were performed at maximum speed i.e. 13,000 rpm at room 
temperature in a tabletop microcentrifuge.  
1) 5 volumes of Buffer PB previously supplemented with pH indicator were added to 1 
volume of the PCR sample and mixed by pipetting. 
a. Indicator was added to the Buffer PB in ratio 1:250 prior to the procedure. 
b. The color of the mixture should be yellow. 
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c. If the color of the mixture turned orange or violet, 10µl of 3M sodium acetate, 
pH5.0 was added.  
2) QIAquick spin column was placed in 2 ml collection tube. 
3) Samples were applied to the columns and spinned for 30-60s. 
4) Flowthrough have been discarded and subsequently 750µl of Buffer PE was added to 
wash the columns. This step was followed by centrifugation for 30-60s. 
5) Flowthrough have been discarded and samples were spinned for additional 1 min in 
order to remove all residual ethanol coming from Buffer PE. 
6) Probes were placed into new 1.5ml microcentrifuge tubes. 
7) DNA was eluted by overlaying the column membrane with 50µ of Buffer EB. 
8) Columns were standing for 1 min and then spinned down for another 1 min in order to 
remove DNA from the membrane. 
9) Samples were stored in -20ºC. 
 
A. Purification of DNA by excision from agarose gel 
It was performed in accordance to the protocol QIAquick Gel Extraction Kit Protocol using a 
microcentrifuge found in QIAquick Spin Handbook supplied by the manufacturer. This 
approach was designed to extract and purify DNA fragments ranging from 70bp to 10kbs 
from standard or low-melt agarose gels in TAE or TBE buffer.  
Note: All centrifugation steps were performed at maximum speed i.e. 13,000 rpm at room 
temperature in a tabletop microcentrifuge. 
1) DNA bands were visualized on the gel using UV light and afterwards excised using 
sharp scalpel.  
2) 3 volumes of Buffer QG were added to 1 volume of the gel piece. 
3) Tubes were incubated at 50ºC for 10 min or until the pieces were completely 
dissolved. Samples were mixed by tapping the tube every 2-3 min. 
4) Yellow is an expected color of the solution after the gel is dissolved. If the mixture 
turned orange or violet, 10µl of 3 M sodium acetate, pH 5.0 was added.  
5) 1 gel volume of isopropanol were added to the sample and mixed. 
6) QIAquick spin columns were placed in a provided 2 ml collection tubes.  
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7) In order to bind DNA, volume of the sample was applied on the column and 
subsequently spinned down for 1 min. 
8) Flowthrough was discarded and QIAquick columns were placed back in the same 
collection tubes. 
9) In order to wash, 750µ of Buffer PE was added on the top of the column and then 
centrifuged for 1 min. 
10) Flowthrough was discarded and column was spinned down for additional 1 min. 
11) Collection tubes were discarded and columns were placed into clean 1.5 
microcentrifuge tubes.  
12) To elute DNA, 30-50µl of the Buffer EB was applied to the centre of the membrane.  
13) Columns were let to stand for 1 min and then spinned for additional 1 min in order to 
elute DNA suspension.  
14) Samples were stored at -20ºC.  
 
B. Purification of DNA by QIAEX II silica particles suspension 
Principles of purification DNA by QIAEX II system involve solubilization of agarose and 
subsequent selective adsorption of nucleic acids. They bound reversibly to QIAEX II silica-
gel particle in the surrounding of chaotropic salt. This approach allows for separation DNA 
from salts, agarose, polyacrylamide, dyes, proteins, and nucleotides. 
1) DNA bands were visualized on the gel using UV light and afterwards excised using 
sharp scalpel. 
2) 400µl of QG solubilization and binding buffer was added along with 10µl f bead 
suspension.  
3) Samples were mixed and incubated for 10 min at 50ºC. Tubes were gently tipped 
during the incubation every 2 min. 
4) Tubes were spinned down for 1 min at 13,000 rpm. 
5) Supernatant was removed. 
6) After adding 500µl of QG buffer steps 4 and 5 were repeated. 
7) After adding 500µl of PE buffer steps 4 and 5 were repeated. 
8) After adding 500µl of PE buffer steps 4 and 5 were repeated once more. 
9) Supernatant was completely removed and tubes were dried for 15 min at the table. 
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10) After overlaying the pellet with 20µl of Elution Buffer (EB), samples were incubated 
for 10 min at 50ºC. 
11) When the incubation was finished, tubes were spinned down for 1 min at 13,000 rpm 
and the pellet was transferred to new tubes. 
12) Samples were stored at -20ºC. 
 
4. Gel electrophoresis 
Electrophoresis is a separation technique which is based on the ability of charged molecules 
to move in an electric field. Its main application is analysis and purification of large 
molecules i.e. proteins or nucleic acids. Procedure is carried out by loading a sample into a 
well moulded in a porous matrix. Afterwards voltage is applied to the entire system. 
Molecules which are sized, shaped or charged differently will move though the matrix at 
various velocities finally creating visible bands.  Matrix components can be versatile, like gels 
made of polyacrylamide, agarose, or starch. Concentration of the gel determines the pores 
size. This affects molecules retardation in a matrix, since small molecules will move faster 
than the big ones. DNA is negatively charged due to its phosphate group and it will migrate 
from the katode (-) to the anode (+) (Western Blotting Principles and Methods; GE Healthcare 
handbook).  During this master thesis horizontal system with 0.8% agarose gel was used. It 
was applied in order to determine the size and the purity of the amplified PCR product as well 
as check the DNA digestion pattern during the restriction analysis.  
Agarose 0.8% 
Per 300 ml of 1 x TAE buffer: 
SeaKem LE Agarose 2.4g 
Gel Green Nucleic Acid Stain (10000x) 20µl 
 
Agarose solution was prepared by dissolving agarose powder in 300 ml of 1 x TAE buffer 
simultaneously warming it up in a microwave until it is completely dissolved. 20µl of Gel 
Green Nucleic Acid Stain (10 000x) manufactured by Biotium was added subsequently and 
the solution was mixed thoroughly. Ready-to- use mix was stored at 60ºC. 
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Protocol: 
1) 0.8% agarose gel with 20µl of Gel Green was prepared according to the description in 
a section above. 
2) Liquid, hot gel was poured into the gel-form placed into the electrophoresis chamber, 
comb with the appropriate number of wells was applied and solution was left to stiffen 
for approximately 30 min.  
3) After this time, electrophoresis chamber was filled with 1xTAE buffer.  
4) DNA ladder was applied to the first well (1 - 2µl). 
5) Samples supplemented with loading dye were loaded into the wells. 
 For PCR product check: 2µl DNA + 7 µl water + 1 µl loading dye 
 For purified PCR product check: 2µl DNA + 7 µl water + 1 µl loading dye 
 For check of restriction cut isolated DNA: 10µl of reaction mix + 1µl loading dye 
 For excision of the DNA from the gel: Entire DNA volume + 2µl loading dye 
6) After assembling the chamber, 100V voltage was applied. Gel was run depending on 
the level of required separation i.e. from 55 min to 120 min.  
7) Resulting bands were visualized with UV-light using Gel Doc 2000. Readout was 
accomplished by comparison of the sample bands to the sizes on the ladder.  
 
5. Restriction analysis 
Restriction analysis of plasmid DNA was performed in order to find the clones containing 
correct plasmids. It is based on the possibility to cut DNA with the enzymes in its adequate 
restriction sites. Reaction was first designed in Clone Manager and later on executed in the 
lab. Results were visualized on the agarose gel by electrophoresis and sizes of the bands were 
determined according to the ladder. Predicted and actual results of the digestion were 
compared and allowed to conclude if the construct is an expected result or not.  
Restriction analysis procedure was set up according to the following ratio: 
DNA………………2µl 
Enzyme……...….0.5µl 
Buffer……………..2µl  
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H2O…………….15.5µl    Total: 20µl 
All the components were mixed together and then incubated in a water bath for 1.5 hour for 
standard enzyme or 30 min for High Fidelity enzyme at the optimal for enzymes 
temperatures. 
  Results were recorded in a way described in section 4 of this chapter. 
 
6. DpnI treatment 
In order to get rid of the original template for the PCR amplification, and digest all methylated 
pDNA, fragments were treated with DpnI.  
Reaction was set up according to the following: 
Purified vector DNA………………17µl 
DpnI ……...................................….1µl 
NEB Buffer 4………….............…..2µl   Total: 20µl 
Components were mixed together in a PCR tube and placed in a cycler set to the program 
DPNJP. Details of the program can be found in a table below. 
Step Temperature Time 
Enzyme digestion 37ºC 3h 
Enzyme inactivation 80ºC 20 min 
Final hold 4ºC ∞ 
 
7. Preparation of chemically competent cells 
Chemically competent cells are used for heat-shock transformation. In other words, it is an 
introduction of a plasmid into the cell. During this project, several strains of competent cells 
were prepared like for instance: DH5α or ET12567. Cell strains used in this thesis are listed in 
the Table 3. 
Protocol: 
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1) Competent cells from frozen stock or single colony from agar plate were incubated 
overnight at 37ºC in 2 ml of LB medium. 
Note: In case of ET12567, cells were incubated with addition of 2µl of 
chloramphenicol (25mg/l) and 1µl kanamycin (50 mg/l) in order to select for the 
helper plasmid.  
2) 0.4ml of the overnight culture was transferred to 40 ml of LB medium and incubated 
for approximately 2h at 37ºC in a shaking incubator (225rpm). Incubation was 
continued until the OD600 reached 0.4 - 0.6. 
Note: As it was noted previously, antibiotics solutions have to be added to ET12567 
cells at this stage as well – chloramphenicol 40µl and kanamycin 20µl. 
3) The cell suspension was spinned down at 4500 rpm for 5 min at 4ºC after reaching 
desired concentration. 
4) Supernatant was removed from the tube and replaced by 4 ml cold TSS-buffer. 
5) Cells were incubated on ice for 1 hour and then aliquoted to several tubes 100µl each. 
6) Cells were stored at -80ºC. 
8. Preparation of electrocompetent cells 
Electrocompetent cells are used during the transformation using the electroporation process. 
Its basis consists of employing electrical pulses to create pores which allow genetic material 
to permeate though the bacterial membrane. DH5α cells were prepared for the need of this 
master thesis. 
Note: All the washing steps were performed on ice. 
1) 300 ml of LB was inoculated with 3 ml of the overnight bacterial culture and 
incubated at 37ºC in a shaker until the OD600 reached 0.35 – 0.4. 
2) When the right concentration of the cells was reached, flask was placed on ice for 20-
30 minutes and occasionally mixed to ensure even cooling of the culture. 
3)  In the meantime, overall volume of the culture was divided among 6 cold cubic tubes, 
resulting in 50 ml of the culture per tube. 
4) The cells were harvested by centrifugation at 2400 rpm for 20 min at 4ºC. 
5) Supernatant was removed and cells were resuspended in 40 ml of ice cold dsH2O. 
6) Step 4 and 5 were repeated with 20 ml of ice cold dsH2O.  
7) Suspensions of 2 bottles were combined resulting in 3, 40ml flasks. 
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8) Cells were spinned down at 2400 rpm for 20 min at 4ºC. 
9) Supernatant was removed and each pellet was resuspended in 20 ml of ice cold, 10% 
glycerol. 
10) Tubes were centrifuged at 2400 rpm for 20 min at 4ºC. 
11) Supernatant was aspirated not disturbing loosely adherent pellet. Cells were gently 
resuspended in 0.5ml ice cold 10% glycerol.  
12) Suspension was aliquoted in a volume of 100µl to 1.5ml microcentrifuge tubes and 
immediately frozen and stored in -80ºC. 
 
9. Transformation 
Transformation is a vital technique used in molecular biology in order to research the 
genomics and proteomics of the microorganisms. It was firstly mentioned by Griffith in 1928 
as a way of uptake of DNA by both prokaryotes and eukaryotes. In his project, he was 
focusing on Pneumococcus and studying acquisition of virulence by the non-virulent strain 
which lack the polysaccharide capsule. He discovered that this feature may be acquired by 
injection of heat-killed virulent bacteria with non-virulent inoculum to the peritoneal cavity of 
the mouse. He called this process “transformation”.  Further studies performed by Avery, 
McLeod, and McCarty identified the “transformation factor” which was DNA. 
It is a process aiming to introduce extracellular DNA into the competent cells. During the heat 
shock or electropulsing step cell wall destabilizes which allows for plasmid to enter the cell. 
Introduced DNA often confers antibiotic resistance genes which make it possible to select 
transformed colonies on the plate. Only colonies bearing the resistance gene will survive on a 
plate with appropriate antibiotic. 
A. by heat shock 
1) Probe with frozen competent cell was slowly melted on ice.  
2) 100µl of competent cells were mixed together with isolated DNA or Gibson ligation 
mix (1-3µl).  
3) Solution was incubated on ice for 30 min. 
4) After this time, cells were heat shocked for 30 sec at 42ºC. Immediately after, cells 
were put back on ice for 2 to 5 min. 
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5) 450-500µ of LB media was added to the samples, mixed and placed for 1 hour 
incubation at 37ºC. 
6) 100µl of transformation mix was spreaded on the plate supplemented with antibiotics. 
7) Plates were incubated overnight at 37ºC. 
 
B. by electroporation 
1) Probe with frozen electrocompetent cell was slowly melted on ice.  
2) 100µl of competent cells were mixed together with isolated DNA or Gibson ligation 
mix (1-3µl).  
3) Solution was incubated on ice for 30 min. 
4) Mix was transferred to an already pre-chilled electroporation cuvette. 
5) Cells were pulsed according to the following setup: 
 Voltage: 2500V 
 Capacitance: 25C  
 Resistance: 100Ω 
 Cuvette: 1mm 
6) Electroporated solution was mixed with 450-500µ of LB media in a 1.5ml 
microcentrifuge tube and placed for 1 hour incubation at 37ºC. 
7) 100µl of transformation mix was spreaded on the plate supplemented with antibiotics. 
8) Plates were incubated overnight at 37ºC. 
 
10. Yeast transformation 
Yeast transformation using protocol for ‘Yeast Transformation by LiAc/SS Carrier DNA/PEG 
Method’ was employed. 
First successful transformation to Saccharomyces cerevisiae was performed by Oppenoorth in 
1960 but unfortunately his results turned out to be impossible to replicate (Gietz and Woods, 
2001). Several methods were developed up-to-date. To mention some of them: lithium 
acetate/single-stranded carrier DNA/polyethylene glycol method, electroporation, agitation 
with glass beads, bombardment with DNA-coated microprojectiles and conversion of 
spheroplasts by treatment with Zymolyase.  
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Technique of yeast transformation which was used during this project is LiAc/SS Carrier 
DNA/PEG method. In order to obtain large number of transformants high-efficiency protocol 
was used. Gietz and Woods work managed to make significant advancements in the available 
protocols resulting in development of four protocols tailored to meet up the needs of several 
projects i.e. the rapid transformation protocol for the introduction of a plasmid into a yeast 
strain; the high-efficiency transformation protocol for recovering large numbers of 
transformants; the large-scale transformation protocol for screening complex plasmid libraries 
such as those required for a two-hybrid screen and the microtiter plate transformation 
protocols 3 for the simultaneous transformation of multiple strains or multiple samples of a 
single strain Gietz and Woods, 2002). 
First reports regarding yeast transformation after treatment with alkali cations appeared in 
1983. It was proved that yeast cells can be stimulated to uptake DNA plasmids by addition of 
monovalent alkali cations like Na+, K+, Rb+, Cs+, and Li+ along with PEG (Gietz and Woods, 
2001). After several modifications, efficiency of this method was increased from 400 to more 
than 1 x 106 transformants/µg plasmid DNA. The key to such an improvement was an 
addition of single – stranded carrier DNA which is a component of transformation mix. Since 
this breakthrough, technique acquired today’s name. Even though the main principles of the 
method were established, it was still possible to better it. As a result of tremendous work, 
technique got simplified and optimized to a present shape. Some of the modifications which 
took place: reduction of exposure to LiAc and removal of TE buffer from the transformation 
mix.  
Main advantage of this protocol which was utilized in this master thesis is an introduction of 
specific plasmid into particular strain of yeast with the focus to recover and analyze number 
of transformants (Gietz and Woods, 2006). Thanks to incubation in double – strength YPAD, 
growth and transformation efficiency significantly increased. After this step cells were 
harvested and washed with water. Further on, they were resuspended in the transformation 
mix which is composed from LiAc, ss-carrier DNA, PEG and plasmid DNA. After incubation 
at 42 ° for 40 minutes, cells were centrifuged, mix was removed and after addition of water 
they were ready for plating. Dilutions were plated onto Synthetic Complete (SC) selection 
medium (Gietz and Woods, 2002). Protocol has many other applications like screening 
multiple yeast genomes for plasmids that are able to complement particular mutation, 
transformation of yeast strain with an integrating plasmid or oligonucleotide, simultaneous 
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transformation of a yeast strain to different plasmids and also transformation of a plasmid 
library into two-hybrid yeast strain. Technique can be employed as a way to generate large 
number of transformants which is needed to screen eukaryotic cDNA libraries (Gietz and 
Woods, 2006). Advantages of this technique in comparison to other transformation methods 
are high efficiency of the process, relatively simple and easily optimized protocol which 
allows for using frozen cells, low cost and finally no demand for any special equipment. 
Drawbacks on the other hand are: requirement of growing cells in overnight culture and 
variability of efficiency in different strains (Gietz and Woods, 2001).  
Transformation mix: 
PEG3500 50% [w/v]…………..…240µl 
LiAc 1.0M…….........................….36µl 
SS carrier DNA (0.2 mg/…...……..50µl  
Plasmid DNA…………….………..34µl 
Total: 360µl 
Protocol: 
Day 1 
1) 3ml of YPAD broth was inoculated with the loop of yeast S. cerevisiae BY4742 or 
10µl of overnight culture and incubated overnight in shaker at 30ºC. 
Day 2 
1) 2.5ml of the culture inoculated the previous day was transferred to 50ml 2xYPAD 
and incubated overnight in a shaker at 30ºC for approximately 4 hours. 
2) In the meantime 1ml of carrier DNA was denatured in a boiling water bath for 5 
min and afterwards chilled immediately on ice. 
3) Cells after the incubation were harvested by centrifugation at 3000g for 5 min. 
4) Pellet was washed twice in 25ml dsH2O and the cells were finally resuspended in 
1ml of dsH2O. 
5) Cell suspension was transferred to 1.5ml microcentrifuge tube and spinned down 
for 30s. Supernatant was discarded. 
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6) Cells were resuspended in 1ml of sterile water and aliquoted, 100µl per each 
transformation reaction. 
7) Tubes were centrifuged at 13,000 rpm for 30s and supernatant was removed. 
8) Transformation mix was prepared according to the description in a section above. 
9) 360µ of mix was added to each transformation tube and resuspended vigorously. 
10) Tubes were placed on a floating rack in a water bath for incubation at 42ºC for 40 
min. 
11) Samples were centrifuged for 1 min and Transformation mix was removed. 
12) 500µl of dsH2O was added to each transformation tube. Pellet was resuspended by 
pipetting or vortexing. 
13) Cell suspension was divided into 5 and plated 100µl per plate on SCM medium. 
14) Plates were incubated for 3-4 days at 30ºC. 
 
11. Conjugative transfer of recombinant plasmid from E. coli ET12567 to S. 
venezuelae  
First reports of intergeneric conjugation between E. coli and Streptomyces are dated 1989. 
From this time, process has been demonstrated also for many Streptomyces species. 
Intergeneric conjugation is used as a way of plasmid transfer where E. coli serves as a donor. 
This technique makes possible to construct and manipulate recombinant plasmids placed in E. 
coli which are later on transferred to Streptomyces (Mazodier et al., 1989). 
E. coli ET12567 containing pUZ8002 which is a RK2 derivative was used in this protocol. 
RK2 represent that the organism is able to replicate in a wide-range of single-cellular hosts. 
pUZ8002 is capable of transferring functions to oriT-carrying plasmids, but due to the 
mutation in its own oriT, its mobility is inhibited (Paget et al., 1999).  
Preparation 
 Spores of S. venezuelae were inoculated on ISP4 plate and incubated at 30ºC for 
approximately 4 days until achievement of dense, confluent lawn. 
 Recombinant plasmid has been transformed to E. coli ET12567 selecting only for one 
vector marker i.e. apramycin. 
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3 transformants were picked from the plate and spread in three sector-divided plate 
onto LA supplemented antibiotics in order to select for the original pUZ8002 and 
assembly-encoded plasmid i.e. with apramycin 100µl/l, chloramphenicol 25µl/l and 
kanamycin 25µl/l. Plates were incubated overnight at 37ºC. 
Protocol 
1) Spore suspension of S. venezuelae was prepared by pouring 5ml of sterile water onto 
the plate and scrapping off the mycelium with the pipette, resuspending it up and 
down and finally filtering the suspension through the sterile cotton pad placed in 5ml 
syringe. 
2) 50µl of spore suspension was transferred to 350µl of 2xYT medium in eppendorf 
tubes. Suspension was thoroughly mixed and incubated for 5min at 50ºC. Samples 
were cooled down at room temperature for the next 5 min. 
3) All the E. coli cells were scrapped off from the corresponding sectors and resuspended 
in 500µl of 2xYT medium in eppendorf tubes. 
4) 100µl of E. coli suspension was added to heat-shocked spores of S.venezuelae, mixed 
and spinned down at 13,000 rpm for 2 min. 
5) Supernatant was removed leaving only 100µl of the total volume of the sample. Pellet 
was resuspended and mixture was spreaded onto the ISP4 plate supplemented with 
MgCl2. 
Note: Plates were dried for 15 minutes at the sterile hood prior to plating. 
6) Conjugation plates were incubated in room temperature for approximately 20 hours 
loosely covered with aluminium foil. 
7) After this time each conjugation plate was overlayed with 1 ml of antibiotic solution 
containing nalidixic acid and apramycin in final concentrations 30µl/ml and 15µl/ml 
respectively. Solution was distributed gently over the entire surface using sterile 
spreader. 
8) Plates were incubated for 3-4 days at 30ºC until visible colonies appeared.  
Modifications for S. albus conjugation: 
 Spores solution was heat-shocked for 10 min at 50ºC. 
 Instead of incubation of conjugation plates in room temperature for 20 hours, plates 
were placed for 20 hours at 30ºC. 
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 Instead of ISP4 with MgCl2, samples were plated on SFM medium supplemented with. 
MgCl2. 
 
12. Second crossover selection  
Second crossover selection was performed in pJP2 S.venezuelae construct. After obtaining 
first crossover strain by conjugation, microorganism was cultivated in three rounds of growth, 
one day each.  
 Experiment was conducted in 2ml TSB medium without antibiotics, incubated at 30ºC 
overnight.  
 100µl culture from the previous day was used as the inoculum for the next one.  
 On the third day 10-6 dilution of the culture suspension was prepared and plated on 20 
ISP4 plates, incubated for 2-3 days until growth was visible at 30ºC. 
 Plates were printed on ISP2 plates supplemented with Am50 using replica plating 
method and incubated for 2-3 days at 30ºC. 
  Results were compared. If the second crossover was successful, clones should lose 
AmR. In this way, clones should grow on ISP4 plate but not on ISP2 Am50. 
Comparison was conducted by putting plates on one another and observing growth. 
 
13. Replica plating 
First general description of replica plating technique was provided by Lederberg & Lederberg 
in 1952. In this master thesis it was used to select the mutants which underwent second 
crossover. Selective medium was ISP2 supplemented with Am50. Mutants susceptible for 
apramycin did not grow on ISP2 Am50 plates. 
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Figure 7. Scheme of replica plating method (modified from the webpage 
http://utminers.utep.edu/rwebb/html/isolation_of_spontaneous_mutat.html) 
 
14. Gibson Assembly 
Gibson assembly is a cloning method which is referred to as “seamless cloning”. It was 
developed by the Daniel G. Gibson from J. Craig Venter Institute (JCVI) along with 
collaboration with Synthetic Genomics Inc. (SGI). Method combines attributes from several 
other solutions in order to create simple, one-step isothermal in vitro recombination 
technology.  
Enzymes used in Gibson Assembly are: 5′ T5 exonuclease, Phusion DNA polymerase and 
Taq DNA ligase. They exploit following enzyme specificities: exonuclease activity – which 
chews back the ends of DNA fragments exposing single stranded DNA overhangs which can 
anneal to their single stranded complement DNA, DNA polymerase activity which fills the 
gaps in the annealed product and DNA ligase activity which covalently seals nicks appeared 
as a result of the assembly (New England Biolabs website). It is possible to use Taq DNA 
polymerase in the place of Phusion DNA polymerase, but since latter possess proofreading 
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activity which avoids presence of noncomplementary sequences, it is highly preferred 
(Gibson et al., 2009). Gibson Assembly gained its popularity due to the simplicity and 
robustness of the method. In order to acquire the successful product, DNA fragments with 
appropriate overlaps and mix of three enzymes with aforementioned specificity are needed. 
Reagents are mixed and incubated at 50ºC for 1h. Resulting product without any further 
modifications is suitable for downstream processing (New England Biolabs website).  Gibson 
Assembly can be used for joining fragments as large as 583 kb and to clone joined products in 
Escherichia coli the size of 300 kb (Gibson et al., 2009).  
There are several advantages of the Gibson Assembly. Firstly, it allows for insertion of one or 
more DNA fragments into theoretically any possible position of the linearized vector. 
Moreover, it is not dependent on the presence of restriction sites in the target sequence. 
Fragments are designed in a way to contain 20 – 40 bps overlaps. Thanks to this method, 
unwanted insertions may be avoided. In addition, significantly larger amount of DNA 
fragments can be joined together. Lastly, reaction is much faster than any other this type of 
solution available so far (New England Biolabs website). The reason for that is possibility of 
mixing all compounds in one isothermal reaction. Since enzymes are not competing with each 
other they can act simultaneously (Gibson et al., 2009). 
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Figure 8. Overview of the Gibson Assembly Cloning Method (New England Biolabs 
website). 
In order to prepare Gibson Mix following components were mixed together: 
5 x isothermal reaction buffer*………………320µl 
10U T5 exonuclease…….......................….0.64µl 
2U Phusion DNA polymerase………………..20µl  
40U Taq DNA ligase………………………..160µl 
H2O………………………………………699.36µl     
Total: 1.2ml 
Gibson Mix was aliquoted to PCR tubes 15µl each and stored in -20ºC. 
*components of 5 x isothermal reaction buffer: 
Tris-HCl (1M)…………………………….…3ml 
MgCl2 (2M)................................................150µl 
dGTP (100mM)............................................60µl 
dATP (100mM)........................................... 60µl 
dTTP (100mM)............................................ 60µl 
dCTP (100mM)……………………...……...60µl 
DTT (1M)………………………………….300µl 
PEG8000……………………………..……….1.5g 
NAD (100mM)………………………….…300µl 
Gibson reaction protocol: 
1) 15µl of Gibson reaction mix was slowly thawed on ice.  
2) 5µl of DNA was added to the tube with the mix. 
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3) Sample was placed in PCR cycler set up for the program OSGIB.  
4) 1-3µl of the reaction mix was used subsequently for transformation, either by heat-
shock or electroporation. Protocol for transformation can be found in 9th section of 
Lab Protocols chapter of this master thesis. 
15. Extraction of chloramphenicol from cultures of S. albus 
Protocol 
1) 1ml of culture was centrifuged at 13,000 rpm for 5 min, then 0.5ml of supernatant was 
transferred to sterile microcentrifuge tube. 
2) 0.5ml of supernatant was overlayed with 0.2ml ethyl acetate and extracted by 
vortexing for 1 min and subsequently centrifuged at 13,000 rpm for 2 min. Arising 
upper phase was transferred to a clean tube.  
3) Ethyl acetate extraction was repeated 2 more times with same volume of ethylacetate. 
4) All the extracts were combined in one tube, making 0.6ml of the liquid. 
5) Samples were open under the fume hood and let stand until all the ethylacetate was 
evaporated. This may last even overnight. For faster evaporation, vacuum drying was 
recommended. 
6) Dry matter was dissolved in 100µl of water and methanol in the ratio 50:50 and stored 
in -20ºC.    
16. Glycerol stocks 
Glycerol stocks were used for long storage of bacterial suspensions at -80ºC. 
Protocol for E. coli glycerol stocks: 
1) 2 ml of overnight culture was transferred to 1.5 microcentrifuge tube, spinned down 
for 2 min at 13,000 rpm. Supernatant was removed.  
2) Pellet was resuspended in 1.5 ml 20% glycerol solution, transferred to Cryo tube and 
stored at -80ºC. 
Protocol for S. venezuelae glycerol stocks: 
1) 5 ml of sterile water was poured onto the confluent plate using the pipette. Surface of 
the plate was gently rubbed, resulting in a spore suspension which was transferred to a 
syringe supplemented with cotton pad sitting in a 5 ml tube.  
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2) Filtered suspension was centrifuged at 5,000 rpm for 5 min. 
3) Supernatant was removed and pellet was resuspended in 1.5 ml 20% glycerol solution, 
transferred to Cryo tube and stored at -80ºC.  
17. Assessment of chloramphenicol production for pJP2 construct 
1) 2 tubes of 3 ml TSB inoculated one with S. venezuelae wild-type and second with final 
pJP2 construct in S. venezuelae were incubated overnight at 30ºC. 
2) 1 ml of each starting culture was transferred to 30 MYM medium and incubated 
further 9 hours. 
3) After this time, each culture was divided into two; one part was supplemented with 1 
ml of 98% ethanol, the other with 1 ml of purified water. Culture was incubated for 
48h at 30ºC in shaking incubator. 
4) Chloramphenicol was extracted using ethyl acetate method. 
5) Samples were sent over for UPLC analysis.  
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Results and discussion 
I. pJP1 and pJP1gusA construct assembly 
pJP1 construct (see Appendix D for plasmid map) was assembled via yeast transformation 
from PCR amplified and purified fragments (according to the setup PCR I which can be found 
in section V. Lab protocols; 2. PCR amplification). It consists of suicide vector amplified 
from pCLY10 template, gusA gene amplified from pUC57 template and its two flanking 
regions amplified from S. venezuelae genomic DNA containing regulatory gene jadR1 and 
structural genes jadF and jadG’. The purpose of creating this plasmid was to remove jadJ-E 
structural genes of S. venezuelae and replace them with reporter gene which when expressed, 
produces β-glucuronidase allowing for detection of quantifiable signal. Since JadR1 acts as a 
positive activator of deleted structural jadomycin gene cluster, functionality of the GUS 
system was planned to be assessed under ethanol shock induction. 
Assembly in S. cerevisiae BY4742 was subsequently transformed to E. coli DH5α. The 
results of restriction analysis with BamHI revealed expected pattern of bands during gel 
electrophoresis i.e. 5.9 kb, 2.3 kb, 1.1 kb, 0.95 kb, 0.46 kb. Due to the slower movement of 
the high G+C content DNA through the gel, bands are positioned slightly higher. 
 
5.9 kb 
2.3 kb 
1.1 kb 
0.95 kb 
0.46 kb 
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Figure 9. Results of restriction analysis of pJP1 construct in E. coli DH5α. Wells from 
the left: DNA ladder; BamHI digested clone no. 1-7, pCLY10 
pJP1 construct was subsequently transformed to E. coli ET12567 and then conjugated to wild-
type strain of S. venezuelae. However, due to the discovered mutation in the gusA gene this 
fragment had to be replaced.  
pJP1gusA assembly - construct for deletion of jadJ-E genes in S. venezuelae with another 
version of  gusA region was performed by firstly amplifying  gusA gene from pSOK808 and 
rest of the assembly using as a template pJP1. Gibson Assembly with subsequent 
transformation to strain like E. coli DH5α, G10 Elite, XL1-Blue or E. cloni 10G was 
attempted. Restriction cutting revealed that none of the clones resulted in acquisition of the 
right construct. This was the reason why GUS assay could not be executed as it was initially 
planned. Gibson Assembly difficulties in obtaining the right construct were expected to be 
connected with high G+C content of Streptomyces genome which facilitates secondary 
structures formation. These may significantly impede formation of the correct construct. Also, 
polymerase mistakes introduced during the PCR could remove restriction sites which resulted 
in wrong pattern of the restriction cutting. 
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II. pJP2 construct assembly 
pJP2 (see Appendix D for plasmid map) assembly fragments were firstly amplified by PCR 
(according to the setup PCR II which can be found in section V. Lab protocols; 2. PCR 
amplification) and subsequently purified on the column. pJP2 is a construct for replacement 
of the cmlI promoter in S. venezuelae with jadJ promoter. It consists of suicide vector 
amplified from pCLY10 template, jadJ promoter and its two flanking regions composed of 
structural genes of chloramphenicol antibiotic cluster amplified from S. venezuelae genomic 
DNA. The idea was to replace cmlI-X promoter with jadJ promoter which is positively 
activated by jadR1 upon ethanol shock and in this way regulate chloramphenicol production. 
Construct was firstly assembled in yeast and then transformed to E. coli DH5α cells. DNA 
was isolated and subjected to restriction analysis. Restriction cutting with EcoRI, EcoRV and 
PstI and subsequent gel electrophoresis resulted in expected pattern of bands. For EcoRI – 3.8 
kb, 3.7 kb, 1.9 kb; EcoRV – 5.2 kb, 3.5 kb, 0.6 kb; PstI – 5.6 kb, 3.8 kb. Pattern for control 
with pCLY10: EcoRI – 4.3 kb, 3.7 kb; EcoRV – 4.4 kb, 3.5 kb; PstI – 5.6 kb, 1.1 kb, 0.7 kb, 
0.6 kb. Digestion with PstI resulted in something which may be suspected as star activity of 
the enzyme. Due to that reason, band on the agarose gel are significantly smeared. 
 
5.2 kb 
1.9 kb 
3.8 kb 
3.7 kb 
3.5 kb 
0.6 kb 
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Figure 10. Results of restriction analysis of pJP2 construct in E. coli DH5α. Wells from 
the left: DNA ladder; EcoRI digested clone no. 1, 2, 3, pCLY10; EcoRV digested clone 
no. 1, 2, 3, pCLY10; PstI digested clone no. 1, 2, 3, pCLY10; ladder. 
pJP2 construct in E. coli DH5α was subsequently transformed to E. coli ET12567 and 
conjugated to wild-type strain of S. venezuelae. PCR products from confirmation test ran on 
the agarose gel resulted in desired band pattern i.e. 5.7 kb for the pair of primers Y10_SVcml-
F + R, 3.8 kb for the pair CmlI-F + CmlX-R. Control with S. venezuelae wild-type was included 
which revealed the following band pattern: no product for the Y10_SVcml-F + R pair; 3.5 kb 
for CmlI-F + CmlX-R. Size of the bands was predicted in Clone Manager software. Setup for 
all PCR programs can be found in Materials and Methods section. 
 
Figure 11. Results of PCR confirmation test. Well order: 1, 17 - ladder; 2-3 clone no.1, 6 
clone no.2, 9-10 clone no.3, 13-14 control - Y10_SVcml-F + R primers; 4-5 clone no.1, 7-
8 clone no.2, 11-12 clone no.3, 15-16 control - CmlI-F + CmlX-R primers. 
 
After the positive confirmation of S. venezuelae transconjugants, second crossover selection 
was performed. Protocol can be found in section V. Lab protocols; 12. Second crossover 
selection. Second crossover selection was based on the hypothesis that due to the homologous 
recombination, construct will loose resistance to apramycin. Using replica plating technique, 
colonies grown on the ISP4 plates were stamped onto ISP2Am50. After 2-3 day incubation, 
results were compared. Clones which kept AmR formed colony, those who lost it however, did 
not. In this way, based on antibiotic resistance selection, screening for second-crossover 
mutants was performed. After total DNA isolation, PCR check was conducted. Control with 
5.7 kb 
3.8 kb 
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wild-type of S. venezuelae strain was added. As in the previous gel, no band with 
Y10_SVcml-F + R primers and 3.8 kb band with CmlI-F + CmlX-R primers was expected. 
Since the clones were sensitive to apramycin, they must have lost the vector, and thus seemed 
to be correct. 
 
Figure 12.  Second crossover selection PCR check. Well order: 1, 14 -  Ladder, 2, 4, 6, 8, 
10, 12 – clones no. 1, 2, 3, 4, 5, control respectively with Y10_SVcml-F + R primers; 3, 5, 
7, 9, 11, 13 – clones 1, 2, 3, 4, 5, control respectively with CmlI-F + CmlX-R primers. 
 
 
Figure 13. Second crossover selection PCR check. Well order: 1, 14 - Ladder, 2, 4, 6, 8, 
10, 12 – clones no. 6, 7, 8, 9, 10, control respectively with Y10_SVcml-F + R primers; 3, 
5, 7, 9, 11, 13 – clones 6, 7, 8, 9, 10, control respectively with CmlI-F + CmlX-R primers. 
3.8 kb 
3.8 kb 
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Since all the clones looked potentially as expected, restriction analysis with HindIII was 
performed as a supplementary test. Simulation in Clone Manager and subsequent 
electrophoresis revealed following band sizes for the right clones: for the pair of primers 
CmlI-F + CmlX-R – 1.9 kb and 1.8 kb. Clones marked red were identified as successful 
double crossovers.  
 
Figure 14. Second crossover transconjugants after restriction cutting with HindIII. PCR 
products from the previous check were subjected for analysis. Wells: 1, 13 – ladder; 2-12 
clones. 
Digestion with HindIII revealed also some false-positive clones. 
Testing of the recombinant S. venezuelae JP2 strain for dependence of chloramphenicol 
biosynthesis on ethanol shock was performed. Experiment was executed according to the 
protocol found in section V. Lab protocols; 17. Assessment of chloramphenicol production 
for pJP2 construct. Chloramphenicol was extracted using ethyl acetate method from four 
samples: 1. S.venezuelae wild-type; control with water, 2. S. venezuelae wild-type; ethanol 
added, 3. S.venezuelae JP2 construct; control with water, 4. S.venezuelae JP2 construct; 
ethanol added.  Samples were sent over for UPLC analysis. Raw results from UPLC are 
presented in the Appendix F.  Chloramphenicol concentration was calculated according to the 
following equation, taking under consideration its molar mass 323.13 g/mol. 
CCml[µg/l] =  µM in the sample x molar mass, converted to [µg/ml] 
1.9 kb 
1.8 kb 
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Table 4. Results from UPLC analysis.  
No. 
Strain of S. 
venezuelae 
Ethanol 
Chloramphenicol 
concentration [µM] 
CCml[µg/ml] 
1. Wild-type - 0.3 0,10 
2. Wild-type + 14 4,52 
3. JP2 mutant - 0.0 0,00 
4. JP2 mutant + 67.6 21,84 
 
 
Figure 15. Chart representing chloramphenicol concentration in the samples from 
UPLC analysis. Numbers on the horizontal axis correspond with number of the sample 
in the Table 3. 
Results from the UPLC revealed surprisingly low chloramphenicol production in  
S. venezuelae wild-type which was not induced by ethanol shock in comparison to the treated 
one. It is unusual due to the fact, that chloramphenicol is a metabolite which is expressed in 
standard conditions. JP2 mutant on the other hand, when not induced, produces absolutely no 
chloramphenicol. When exposed to ethanol shock however, it produces five times more 
antibiotic than ethanol-shocked wild-type strain.  
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This data support the main objective of this master thesis which was re-wiring of the 
antibiotic biosynthesis regulation in S. venezuelae. Exchange of the promoter which drives 
expression of chloramphenicol structural genes caused its production completely dependent 
on the ethanol shock. 
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III. pCML3 construct assembly 
pCML3 is a construct assembled for  heterologous expression of antibiotic gene cluster from 
S. venezuelae in S. albus. S. albus was chosen as a suitable organism for this experiment 
because it doesn’t produce chloramphenicol. S. venezuelae on the other hand is a natural 
producer of chloramphenicol. Approach consisted of cloning the fragment of DNA of 
producing microorganism along with gene cluster of interest and attempting to express it in 
suitable host.  
PCR of the fragments was performed according to the setup described in section PCR III 
which can be found in V. Lab protocols; 2. PCR amplification. Assembly consists from vector 
amplified from pCLY10 template and two additional fragments using genomic DNA from  
S. venezuelae as a template. They include structural genes of chloramphenicol biosynthetic 
gene cluster. After purification of the fragments they were transformed to yeast and 
subsequently introduced to E. coli DH5α. Digestion with EcoRI and PvuII resulted in desired 
band localization on the agarose gel during electrophoresis. For EcoRI: 15.9 kb, 7.5 kb 3.7 kb, 
3.0 kb; PvuII: 12.0 kb, 6.9 kb, 6.0 kb, 2.1 kb, 1.8 kb, 1.2 kb. Control with pCLY10 cut with 
EcoRI: 4.3 kb, 3.7 kb; PvuII: 8 kb. As a supplementary ladder due to the big size of construct, 
isolated DNA from phage lambda cut with HindIII was used. Fragments are 23.1 kb, 9.4 kb, 
6.6 kb, 4.3 kb, 2.3 kb, 2.0 kb, 0.5 kb. 
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Figure 16. Restriction analysis of DNA isolated from E. coli DH5α clone. Wells from the 
left: 1. 1 kb Ladder, 2. Lambda HindIII Ladder, clone no. 1 cut with EcoRI, clone no. 1 
cut with PvuII, clone, pCLY10 cut with PvuII, pCLY10 cut with EcoRI. 
Subsequent transformation to E. coli ET12567 cells and conjugation to S. albus J1074 
resulted in one transconjugant from which DNA was isolated and checked by PCR. Control 
with S. venezuelae wild-type carrying chloramphenicol cluster was added and samples were 
run on the agarose gel. Expected band pattern was obtained and it allowed proceeding to the 
further part of the experiment. Simulation of PCR product with primers Cml3H1-F + R 
resulted in fragment of 11.69 kb; with Cml3H2-F + R – 11.77 kb. Control had same fragment 
sizes.  
15.9 kb 
3.7 kb 
3.0 kb 
2.1 kb 
1.8 kb 
1.2 kb 
12.0 kb 
7.5 kb 
6.9 kb; 6.0 kb 
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Figure 17. PCR confirmation check. Wells: 1. 1 kb Ladder; 2. Lambda HindIII Ladder; 
3, 4 – clone, Cml3H1-F + R primers; 5, 6 – clone, Cml3H2-F + R primers; 7, 8 –  
S. venezuelae control, Cml3H1-F + R primers; 9, 10 - S. venezuelae control, Cml3H2-F + 
R primers. 
Recombinant S. albus carrying pCML3 was then subjected to incubation, first in 2 ml TSB 
with Nal30 and Am50 overnight at 30ºC. Consequently, 500µl of the starter culture was 
transferred to 50 ml PM4-1 and NZA media, and incubated for 7 days in shaking incubator at 
30ºC. Negative control with pCLY10 in S. albus was added. After that time, cultures were  
extracted with ethyl acetate for assessment of chloramphenicol production. Tubes were 
handed out for assessment of chloramphenicol content by UPLC analysis to external lab. 
Unfortunately, no chloramphenicol production was detected for the tested strains. 
1. Complementation experiment 
In addition to the attempt of heterologous expression of chloramphenicol cluster from 
pCML3, complementation experiment was performed. Double deletion S. venezuelae mutant - 
JadRI/CmlΔ was provided by the colleague from the lab Jianhai Zhang. The idea was to 
introduce chloramphenicol structural genes and complement the deletion. In order to ensure 
that and avoid interference, chloramphenicol gene cluster in deletion mutant had to be 
completely removed. In addition, due to the deleted jadR1 gene, introduction of 
chloramphenicol genes will lead to its overproduction. It is caused by the lack of repression 
normally enforced by jadR1. JadRI/CmlΔ S. venezuelae was conjugated with pCML3 E. coli 
ET12567. Transconjugants were checked by PCR amplification and subsequent 
11.77 kb 
11.69 kb 
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electrophoresis analysis. Bands were simulated in Clone Manager and expected as follow: for 
the clones – primers Cml3H1-F + R 11.69 kb and primers Cml3H2-F + R 11.77 kb. Control 
with S. venezuelae WT was added. Size of the bands is the same like for the transconjugants. 
Correct results are marked red.  
 
Figure 18.  PCR confirmation check. Wells: 1. 1 kb Ladder; 2. Lambda HindIII Ladder; 
3, 5, 7, 9, 11 – clones no. 1, 2, 3, 4, control - Cml3H1-F + R primers; 4, 6, 8, 10, 12 – 
clones no, 1, 2, 3, 4, control - Cml3H2-F + R primers.  
Similarly to the previous experiment, 2ml TSB was inoculated with complemented S. 
venezuelae mutant for overnight incubation at 30ºC. 500µl of next day culture served as 
inoculum for 7 days incubation in 50 ml PM4-1 in shaking incubator at 30ºC. Along with that 
construct, positive control with S. venezuelae wild-type and negative with S. venezuelae 
JadRI/CmlΔ mutant were conducted. After incubation, chloramphenicol was extracted with 
ethyl acetate, and in order to assess the amount of the antibiotic in the cultures, samples were 
sent for UPLC analysis. No chloramphenicol production was observed in the complemented 
mutant. Negative control – non-complemented mutant, resulted in no chloramphenicol 
production. Positive control - wild-type S. venezuelae produced significant amount of 
chloramphenicol.   
pCML3 construct was successfully assembled during the span of this master thesis, 
demonstrating usefulness of both pCLY10 vector and yeast-based DNA assembly for rapid 
cloning of gene clusters. PCR confirmation tests revealed appearance of the correct clones. 
When checking the functionality of the construct by assessment of chloramphenicol 
production by UPLC, it was revealed that the cluster is not working properly, as no 
11.77 kb 
11.69 kb 
76 
 
chloramphenicol was detected in the samples. It might be expected that the reason for non-
functional construct are mistakes introduced during PCR by polymerase. Due to the high G+C 
content of the Streptomyces DNA, polymerase is more likely introducing mutations. Nothing 
happen when the place of mutation resides in not essential part of the genome. However if it 
disrupts one of the vital genes, it may impede the functionality of the whole cluster. Most 
likely this was the case here.  
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Future recommendations 
Many of the significant obstacles in this master thesis most likely arose from the mutations 
introduced by DNA polymerase during PCR. If those could be avoided, results of the 
experiments wouldn’t be based in such a great extent on chance. Artificial gene synthesis 
offers solution to these problems but it is too expensive at the moment to include it in 
everyday lab routines. With the time, like any other developed technology so far, it will 
become certainly cheaper. Affordable price will make it possible to increase its use.   
Conclusions 
During the time span of this master thesis four constructs were attempted to be assembled. 
pJP1 – construct for deletion of of jadJ-E genes in S. venezuelae; pJP1gusA – construct for 
deletion of the jadJ-E genes in S. venezuelae with another version of gusA region; pJP2 – 
construct for replacement of the cmlI promoter in S. venezuelae with jadJ promoter and 
pCML3 – construct for heterologous expression of chloramphenicol antibiotic gene cluster. 
pJP1 assembly due to the discovery of mutations in gusA gene had to be discontinued, and a  
pJP1gusA version carrying verified functional reporter should have been constructed instead. 
Experiment was designed in a way, that functional version of gusA will be joined together 
with remaining part of the plasmid via Gibson Assembly. Due to several possible reasons, 
assembly did not work out and GUS assay for testing gusA gene expression upon ethanol 
shock could not be carried out. As mentioned before, most of the difficulties arose due to the 
mutations acquired during PCR amplification. In the end, however, the main goal of the 
master thesis was achieved by assembling pJP2 construct and replacing cmlIp with jadJp 
promoter. The results from this experiment, confirmed possibility of re-engineering antibiotic 
biosynthetic regulation by exchanging the promoter governing the expression of structural 
genes. Analysis of chloramphenicol production in the engineered strain revealed that it 
produced no chloramphenicol without ethanol shock, while in the case of ethanol addition, 
production was increased by 5 fold in comparison to the ethanol-shocked wild-type strain. 
Another important observation is that upon continuous cultivation in the MYM medium 
ethanol shock induces chloramphenicol biosynthesis, which has not been reported previously.   
Additional experiment regarding heterologous expression of antibiotic gene clusters was 
performed. Results confirm positive construction of the assembly in heterologous host i.e.  
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S. albus as well as complementation of the double mutant strain in S. venezuelae, but due to 
mutations introduced by PCR,  both constructs turned out to be non-functional. For that 
reason, it is difficult to drag any final conclusion regarding these experiments, while high-
fidelity DNA polymerase capable of amplifying DNA with high GC content (>70%) may  
solve the problem. 
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Appendix 
I. Appendix A: Media recipes 
1. ISP2 medium 
ISP2 and ISP4 media were developed for characterization of Streptomyces species according 
to International Streptomyces Project (ISP).  
ISP Medium 2 is also referred in literature to as Yeast Extract-Malt Extract Agar. 
Content: (Per 1L of water) 
Yeast Extract 4.0 g 
Malt Extract 10.0 g 
Dextrose 4.0 g 
Agar 20. g 
 
38g of powder Difco™ ISP Medium 2 from dehydrated product was suspended in 1L of 
purified water. Subsequently medium was autoclaved at 121ºC for 20 min. 
For conjugation purposes, plates with ISP4 were supplemented with 1M MgCl2 in 
concentration 1 ml per 100 ml media. 
2. ISP4 medium 
ISP Medium 2 is also referred in literature to as Inorganic Salts-Starch Agar. 
Content: (Per 1L of water) 
Soluble Starch 10.0 g 
Dipotassium Phosphate  1.0 g 
Magnesium Sulfate USP 1.0 g 
Sodium Chloride 1.0 g 
Ammonium Sulfate 2.0 g 
Calcium Carbonate 2.0 g 
Ferrous Sulfate 1.0 mg 
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Manganous Chloride 1.0 mg 
Zinc Sulfate 1.0 mg 
Agar 20.0 g 
 
37g of powder Difco™ ISP Medium 4 from dehydrated product was suspended in 1L of 
purified water. Medium was autoclaved at 121ºC for 20 min. Prior to dispensing it to Petri 
dishes, medium was thoroughly mixed.  
3. ISP4 medium with MgCl2 
It was used as conjugation plate with the procedure of conjugative transfer of recombinant 
plasmid from E. coli to S. venezuelae.  
Medium was prepared according to the procedure described above. After autoclaving 1M 
MgCl2 was added in amount 1ml per 100 ml medium.  
4. LA medium 
Luria Agar (LA) medium is nutritionally rich medium widely used in cultivation and 
maintenance of various strains of E. coli. 
Per 1L of purified water: 
Tryptone 10.0 g 
Yeast Extract 5.0 g 
NaCl 10.0 g 
Agar 15.0 g 
 
Ingredients were suspended in water and then autoclaved at 121ºC for 20 min. 
5. LB medium 
Luria Broth (LB) medium has the same content as previously described LA medium, with the 
omission of agar in its components. Thus, its properties are same as well. 
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6. MYM medium 
MYM medium was used for cultivation of S. venezuelae. 
Per 1L of purified water: 
Maltose 4.0 g 
Malt extract  10.0 g 
Yeast extract 4.0 g 
MOPS Na-salt 1.9 g 
 
Ingredients were suspended in water and then autoclaved at 121ºC for 20 min. 
7. NZA medium 
It is used for cultivation and maintenance of several Streptomyces species. 
Per 1L of purified water: 
Starch soluble 20.0 g 
Glucose  10.0 g 
Yeast extract 5.0 g 
N-Z Amine 5.0 g 
Calcium Carbonate 1.0 g 
Agar 15.0 g 
 
All the components were mixed in 1L of water and then autoclaved at 121ºC for 20 min. 
8. PM4-1 medium 
Per 1L of purified water: 
Glucose 15.0 g 
Soy meal 15.0 g 
Corn Steep solids 5.0 g 
CaCO3 2.0 g 
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TMS 1 (trace elements)* 6.0 ml 
 
Composition of TMS 1 stock solution (filter-sterilized) per 1L water: 
FeSO4∙7H2O 5000 mg 
CuSO4∙5H2O 390 mg 
ZnSO4∙7H2O 440  mg 
MnSO4∙H2O 150 mg 
Na2MoO4∙2H2O  10 mg 
CoCl2∙6H2O 20 mg 
HCl 50 ml 
 
Prior to preparation the medium 150 g/l sterile glucose solution was prepared. 5g of corn 
steep solids was dissolved in 890 ml distilled water. After addition of magnetic stirrer to the 
bottle, 15 g of soy meal and 2 g of CaCO3 was added to the solution. At this stage, medium 
was sterilized for 20 min at 121ºC. 100 ml glucose solution and 6 ml TMS1 was 
supplemented subsequently.  
9. SCM medium 
SCM is an abbreviation from Synthetic Complete Selection Medium. It is used for selection 
of transformants with specific genetic marker carried by plasmid by omission of specific 
components from Amino Acid Mix. 
Per 800 ml purified water: 
Yeast Nitrogen Base w/o amino acids 5.4 g 
Amino acid mix 1.6 g 
Glucose 16.0 g 
Agar 12.0 g 
 
Amino Acid Mix contains: 
Adenine SO4 0.5 g 
89 
 
Arginine 2.0 g 
Aspartic Acid 2.0 g 
Glutamic Acid 2.0 g 
Histidine HCl 2.0 g 
Inositol 2.0 g 
Isoleucine 2.0 g 
Leucine 4.0 g 
Lysine HCl 2.0 g 
Methionine 2.0 g  
Phenylalanine 2.0 g 
Serine 2.0 g 
Threonine 2.0 g 
Tryptophan 2.0 g 
Tyrosine 2.0 g 
Uracil 2.0 g 
Valine 2.0 g 
p-Aminobenzoic acid 0.2 g 
 
Components marked with bold type are omitted in SC selection medium. 
Medium was prepared by mixing all the ingredients together but glucose which was 
supplemented after autoclaving. It was sterilized for 20 min at 121ºC. Medium has to be 
stored in 4ºC and the darkness due to its light-sensitivity. 
10. SFM medium 
Often referred in literature as to Mannitol Soy Agar medium. 
Per 1L of purified water: 
Mannitol 20.0 g 
Soya flour 20.0 g 
Agar 20.0 g 
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Medium was sterilized for 20 min at 121ºC. Prior to pouring onto the plates, it was mixed 
vigorously in order to rise up the pellet and ensure equal distribution of the components on 
each plate. 
For conjugation purposes, SFM plates were supplemented with 1M MgCl2 in concentration 
1ml per 100ml media. 
11. TSB medium 
Name is an abbreviation from Tryptic Soy Broth, called also Soybean-Casein Digest Medium. 
It is used as general purpose medium, being successfully implemented as a medium used for 
cultivation a wide range of microorganisms. It is consisted of following compounds per liter 
of purified water: 
Enzymatic Digest of Casein 17.0 g 
Enzymatic Digest of Soybean Meal 3.0 g 
Sodium Chloride 5.0 g 
Dipotassium Phosphate 2.5 g 
Dextrose 2.5 g 
 
 It was prepared from the ready-to-make powder mix from a supplier according to the 
instructions on the package. Subsequently, medium was autoclaved for 20 min at 121ºC. 
12. YPAD Broth medium; 2xYPAD Broth medium 
Abbreviated name from Yeast Extract-Peptone-Adenine-Dextrose Medium. Commonly, it is 
used in research as a general medium for cultivation of yeast strains. Double strength 
alternative of the solution allows for re-growing culture suspension back to log-phase.  
Medium can be prepared in three variants: YPAD Agar, YPAD Broth and 2xYPAD Broth. 
Recipe to obtain 800 ml is presented below.  
 YPAD Agar YPAD Broth 2xYPAD Broth 
Bacto YPD Agar 50.0 g - - 
Bacto YPD Broth - 40.0 g 80.0 g 
Distilled/deionized water 800 ml 800 ml 800 ml 
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Medium was sterilized for 20 min at 121ºC. 
13. 2xYT medium 
It is very rich medium, facilitating and excellent growth of many recombinant strains of  
E. coli. It has been also exploited in the propagation of M13 bacteriophage.  
Per 1L of purified water: 
Tryptone 16.0 g 
Yeast Extract 10.0 g 
NaCl 5.0 g 
 
Medium was autoclaved for 20 min at 121ºC. 
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II. Appendix B: Buffers and Solutions 
1. Antibiotic solutions 
Antibiotic stock solutions were prepared by dissolving antibiotic salt in an adequate amount 
of solvent. Solutions were stored in -20ºC. 
Apramycin (100mg/ml) 
Apramycin 0.5g 
dsH2O 5 ml 
 
Chloramphenicol (25mg/ml) 
Chloramphenicol 125 mg 
Absolute ethanol 5 ml 
 
Kanamycin (25mg/ml) 
Kanamycin 125 mg 
dsH2O 5 ml 
 
Nalidixic acid (30mg/ml) 
Nalidixic acid sodium salt 150 mg 
NaOH (1M) 5 ml 
 
2. Buffers 
50 x TAE buffer 
Used for gel electrophoresis. 
Recipe per 1L of purified water: 
Tris base 242g 
EDTA 0.5M pH 8 100 ml 
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Acetic Acid (100%) 57.1g 
 
Buffer was autoclaved for 20 min at 121ºC. 
TSS buffer 
Used for preparation of competent cells. 
For 50 ml of the ready-to-use buffer following components were mixed: 
PEG8000 5g 
MgCl2 (1M) 1.5ml 
DMSO 2.5ml 
LB medium 42.5ml 
 
Solution omitting DMSO was autoclaved for 20 min at 121ºC. DMSO was added 
subsequently and buffer was stored at 4ºC. 
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III. Appendix C: List of primers 
Primer Sequence 
Y10_SVF1 TGGACGTTCGAGGAGAACCTGCAGGTCGACTCTAGAGG 
Y10_SVR1 TAATGGCGGCGTCACTTCCACACGCGTCAGACGGAC 
JJEdel-F GTCCGTCTGACGCGTGTGGAAGTGACGCCGCCATTAAC 
JJEdelL-R2 CTCGACCGGCCTCAGCATGACGGTTTCAACTCCTGATCG 
JJEdelR-F TCCGACCCGGCGAAGCTTCCTGGCAGAGAAGAGACGA 
JJEdelR-R TCTAGAGTCGACCTGCAGGTTCTCCTCGAACGTCCAGT 
gusAF2 TCAGGAGTTGAAACCGTCATGCTGAGGCCGGTCGAG 
gusAR2 CGTCTCTTCTCTGCCAGGAAGCTTCGCCGGGTCGGATAC 
Y10_SVcml-F GCTCAGCAGCGGCAGCACCTGCAGGTCGACTCTAGAGG 
Y10_SVcml-R CTTCGACGAACTGCTCAGCACACGCGTCAGACGGAC 
CmlI-F GTCCGTCTGACGCGTGTGCTGAGCAGTTCGTCGAAGG 
CmlI-R TCAGGAGTTGAAACCGTCATGCGTGACCACACGGACG 
jadJp-F GTCCGTGTGGTCACGCATGACGGTTTCAACTCCTGATCG 
jadJp-R CGGTTCCTTCAGTTGCACCACATTCCCGTCCTCGTGATCC 
CmlX-F CACGAGGACGGGAATGTGGTGCAACTGAAGGAACCGGAC 
CmlX-R TCTAGAGTCGACCTGCAGGTGCTGCCGCTGCTGAGC 
Y10cml3-F AACTGCCGGACGACGAACTGCTGCAGGTCGACTCTAGAGGATCCG 
Y10cml3-R TATCCGCAGCGCCGCCTGTTCGAAGTTCACCGAAGAGCGCATTTTC 
Cml3H1-F GCGCTCTTCGGTGAACTTCGAACAGGCGGCGCTGCGGATATTACG 
Cml3H1-R TCCACTGCGGCTACCAGGTCAACCAC 
Cml3H2-F GTCGTAGTACTCGGAGGCGTACATCAG 
Cml3H2-R CCTCTAGAGTCGACCTGCAGCAGTTCGTCGTCCGGCAGTTCCTTC 
JP1-F CGACTCTAGAGGATCGATCACAGACCCTGACCACACTC 
JP1-R CGATCGATGCGATCGACTCGCCTTCTCCGTACCC 
gusA_JP-F GGAGAAGGCGAGTCGATCGCATCGATCGAAGGAGAGTTCACCA 
gusA_JP-R GGTCAGGGTCTGTGATCGATCCTCTAGAGTCGACCTGCAGT 
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IV. Appendix D: Plasmid maps 
 
Figure 19. Template vector for construction of assemblies. 
 
Figure 20. Template vector for gusA gene. 
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Figure 21. Construct for deletion of jadJ-E genes in S. venezuelae. 
 
Figure 22. Construct for deletion of jadJ-E genes in S. venezuelae with the exchanged 
gusA region. 
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Figure 23. Vector for replacement of the cmlI promoter in S. venezuelae with jadJ 
promoter. 
 
Figure 24. Construct for testing possible heterologous expression from the antibiotic 
cluster. 
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V. Appendix E: Gel electrophoresis ladder 
The ladder used in electrophoresis is presented in a figure below.  
 
Figure 25. The sized of the bands using Thermo Scientific O’Gene Ruler 1kb DNA 
ladder ready-to-use 0.1µg/µl. 
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VI. Appendix F:  Results from UPLC analysis 
Raw data 
Strain of S. venezuelae Ethanol 
Chloramphenicol 
concentration [µM] 
Wild-type - 0.3 
Wild-type + 14 
JP2 mutant - 0.0 
JP2 mutant + 67.6 
 
